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“The important thing is not to stop questioning.  
Curiosity has its own reason for existing.” 
- Albert Einstein 
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Cells are composed of billions of biomolecules, all of which have defined 
properties that enable them to coordinate cellular activities in both health and 
disease. To dissect these molecular properties, tools are required to enable 
researchers to track biomolecules within their native environments. It is for this 
purpose that numerous methods have been developed to equip biomolecules 
with reporter tags for visualisation within, and isolation from, biological samples. 
Most renowned among these are genetic protein tagging and antibody labelling 
approaches that have provided profound insights into protein function within 
cellular processes. However, these strategies are predominantly amenable to 
protein labelling and can not be applied to the study of other biomolecular classes, 
such as glycans, lipids, or metabolites.  
 
To allow the analysis of biomolecules beyond the scope of the aforementioned 
labelling techniques, bioorthogonal chemistry was developed at the turn of the 
millennium.1 Bioorthogonal chemistry is a chemical labelling strategy applicable to 
the study of a multitude of biomolecules, including nucleic acids, proteins, glycans 
and lipids. Its mechanism relies on a two-step labelling sequence, where a small 
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chemical reporter is installed onto a biomolecule of interest, which is 
subsequently ligated to a detection group upon a chemical ligation reaction 
(Figure 1).2, 3 Chemical reporters can be installed upon the introduction of 
functionalised metabolites into the growth medium, such as nucleotides or amino 
acids, which are then incorporated by the cell’s own metabolic machinery 
(reviewed in4). Subsequently, functionalised metabolites are chemically 
conjugated to a fluorescent or affinity group for detection purposes. This 
conjugation reaction can take place in a physiological setting and does not 




Figure 1: A chemical reporter (grey circle) linked to a metabolite (grey box) is introduced into a 
target biomolecule by the cell’s own biosynthetic machinery. In the second step, the reporter is 
covalently ligated to an exogenously added detection group, also functionalised with a chemical 
reporter (yellow star). Chemical reporters must be solely reactive towards each other, avoiding side 
reactions with non-target biomolecules (blue shapes). 
 
Imaging of bioorthogonally functionalised biomolecules  
Due to the wide range of functionalised metabolites, the broad spectrum of 
ligation reactions and the diversity of available detection groups, bioorthogonal 
chemistry has been of great value to the field of imaging. One of the first imaging 
studies that explored bioorthogonal chemistry was a study by Chang et al., in 
which the labelling and imaging of glycans was reported for various mammalian 
cell lines.5 Since this inception, applications for the use of bioorthogonal chemistry 
have been ever expanding, especially through diversification of available 
detection groups, such as fluorogenic6, 7 and near infra-red8 probes for 
fluorescence imaging purposes. However, thus far, no studies have been reported 
that allow visualisation of bioorthogonal groups with electron microscopy (EM) 
approaches. With EM, cellular ultrastructures can be revealed at nanometer 
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resolution, making it the method of choice for analysis of the cell’s ultrastructural 
environment wherein biomolecules of interest reside.9 Since this information can 
be of great value to the study of cellular biomolecules, it is the aim of this thesis to 
explore combinatorial use of bioorthogonal labelling and EM-based imaging 
techniques to enable observation of specific molecular targets in their 
ultrastructural context within the cell.   
 
Aim and outline of this thesis 
In chapter 1 the principles of EM-imaging for biochemical research are discussed, 
including two different types of electron microscopes and various techniques to 
prepare specimens for transmission electron microscopy. Chapter 1 additionally 
describes several labelling strategies that can be employed to identify the 
molecular identity of EM-revealed structures. One of these approaches; 
correlative light and electron microscopy (CLEM) imaging, is explained by means 
of two generally used CLEM strategies; live-cell CLEM and on-section CLEM. 
 
In chapter 2 the importance and potential of bioorthogonal chemistry for CLEM is 
emphasised. In this review an overview is given of frequently used bioorthogonal 
ligation strategies for imaging, including the copper-catalysed Huisgen 
cycloaddition, the strain-promoted cycloaddition, the inverse electron-demand 
Diels-Alder cycloaddition and the photoclick reaction. In addition, inroads that 
have been made towards the CLEM-imaging of bioorthogonal functionality are 
reviewed, including azide-modified gold particles, bioorthogonally functionalised 
selenide/zinc sulphide core-shell quantum dots and bioorthogonally 
functionalised fluorophores that are capable of photooxidizing diaminobenzidine. 
 
Chapter 3 describes the development of two methods for the EM-detection of 
bioorthogonal labels in cryo-sectioned biological samples. The first method is a 
gold labelling strategy that allows for the direct detection of bioorthogonal tags in 
the electron microscope. The second method is a CLEM-based imaging method in 
which bioorthogonal tags are detected with fluorescence microscopy (FM) after 
which EM imaging is performed and images of both FM and EM are correlated. 
 
Chapter 4 describes an in-depth analysis of gold and fluorescence labelling for 
EM-imaging. Upon comparison of these labelling strategies it is shown that there 
exist inherent discrepancies between the fluorescence signals and the distribution 
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of gold particles. This was demonstrated by several examples and is characterised 
upon use of the techniques developed in chapter 3; the on-section gold and 
fluorescence labelling of bioorthogonal tags for EM imaging. 
 
In chapter 5 the CLEM technique described in chapter 3 is applied to the imaging 
of bacterial processing in the phagolysosomal system of phagocytic cells. The in 
situ study of bacteria in the phagocytic pathway is very difficult, as genetic 
modification is often complicated and, if successful, only allows the tracking of 
pathogen phagocytosis up until the degradation of the genetically encoded 
protein reporters. In  chapter 5 it is shown that detection of bioorthogonal groups 
by CLEM allows acquisition of high resolution information on the subcellular 
location of the bioorthogonally-labelled bacteria, even after the proteolytic 
degradation of genetically encoded protein reporters. 
 
Many bacterial pathogens have evolved clever strategies to subvert and exploit 
the immune response in order to enter and replicate in eukaryotic cells. A prime 
example of such a bacterial pathogen is Salmonella enterica. Upon the injection of 
effector proteins Salmonella modulates the host cell environment and as such 
ensures its own replication. In chapter 6 the CLEM strategy previously reported in 
chapter 5 is applied to the imaging of bioorthogonally-labelled Salmonella upon 
implementation of stochastic optical reconstruction (STORM)-super resolution 
imaging in the CLEM imaging sequence. This strategy has great potential to 
elucidate the temporal and spatial injection of Salmonella virulence factors and 
their interactions with host cells organelles. 
 
In chapter 7, the potential of CLEM-based imaging of bioorthogonal functionalities, 
is explored for the imaging of active enzyme populations using activity-based 
probes (ABPs). The CLEM imaging of active cysteine protease populations is 
demonstrated upon use of both two-step and direct ABP labelling approaches. It 
is shown that with both strategies active populations of cysteine proteases can be 
labelled in a similar fashion with high selectivity and efficiency. In addition it is 
shown that with direct ABPs multiple enzyme populations can be simultaneously 
CLEM imaged and their relative ultrastructural location can be determined.  
 
In the concluding chapter 8, all findings are summarised and alternative and 
future applications of the developed technique are suggested. These include 
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bioorthogonal diaminobenzidine labelling; 3D-CLEM imaging of bioorthogonally-
labelled bacteria in phagocytic cells; incorporation of bioorthogonal amino acids in 
Salmonella mutant strains and improvements for CLEM-ABP imaging.  
- 11 -
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Electron Microscopy for Biochemical Research 
The magnification power of an electron microscope (EM) can reach over a 
thousand times beyond that of a conventional light microscope and allows 
scientists to study specimens with nanometer scale resolution.1 The EM is 
therefore the main tool for the imaging of cellular ultrastructures and has given 
rise to many observations that form the foundation of modern cell biology. 
Virtually all organelles and cell inclusions were either discovered or resolved in 
finer detail using the EM. These descriptions have laid the foundation for 
experimental manipulations directed at unravelling cell function and 
understanding how cellular structures vary in normal, experimental, and diseased 
states.  
Electron microscopes 
Generally two different types of electron microscopes are used for biological 
research; the scanning electron microscope (SEM) and the transmission electron 
microscope (TEM) (Figure 1). The SEM is commonly used to obtain three-




specimens and makes use of a low-energy electron beam (~0.2 keV to 40 keV) 
that scans the surface of a specimen. When this beam strikes the specimen, low 
energy secondary electrons are produced from the uppermost layers of the 
specimen, that are collected, processed, and eventually translated into an image.2, 
3  
 
The transmission electron microscope (TEM) transmits a high-energy electron 
beam (120-300 keV) through a specimen. The TEM can be used to study (the 
interior of) bacterial, mammalian and plant cells as well as viruses and proteins, 
and provides a two-dimensional image of the substructures that these specimens 
consist of.2, 4 
 
 
Figure 1: Basic principles of the transmission electron microscope (TEM) and the scanning electron  
microscope (SEM) (adapted from 2).  
 
TEM sample preparation; fixation, dehydration, embedding, sectioning and 
staining 
Biological samples cannot be imaged with the electron microscope whilst alive. 
The vacuum in the column of the EM -necessary for the coherent targeting of the 
electron beam- evaporates water in (living) biological samples and this causes 
damage to both the sample and the EM. Moreover, at the location where the 
(high-)energy electron beam hits the sample temperatures are elevated. Biological 
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samples must therefore be dehydrated prior to EM analysis. For small samples, 
such as purified proteins or virus particles, this can be done by air-drying or rapid 
freezing. However, larger biological samples need additional sample preparations, 
such as fixation and dehydration. Moreover, since with TEM the electron beam is 
transmitted through the sample, biological specimens such as mammalian cells 
need to be sectioned into ultrathin sections (30 to 150 nm), which requires 
hardening of the sample. Throughout the years many protocols have been 
developed to ensure the TEM analysis of biological samples and can be broadly 
grouped into; cryo-fixation strategies for cryo-EM analysis, whereby chemical 
fixation dehydration, plastic embedding and staining are obsolete; freeze-
substitution strategies, whereby samples are first cryo-fixed after which frozen 
water is dissolved by organic solvents that contain chemical fixatives and chemical 
fixation strategies whereby samples are chemically fixed after which freezing or 
resin embedding can be performed. In the next part of this chapter the main used 
chemical fixation strategies will be discussed that can be used for the TEM 
analysis of mammalian cells.  
 
Aldehyde fixation 
Fixation is usually the first step of TEM sample preparation and protects the 
sample against disruption during embedding, sectioning and electron beam 
exposure. Generally the aldehydes glutaraldehyde and (para)formaldehyde are 
used for the (primary) fixation of a biological EM sample. Glutaraldehyde is a five-
carbon compound that contains terminal aldehyde groups that primarily react 
with the amino groups of lysines (amino acids), and -to a lower extent- with lipids, 
carbohydrates, and nucleic acids (Figure 2A).2 Formaldehyde forms methylene 
hydrate in aqueous solutions that primarily reacts with the side chains of amino 
acids and forms reactive hydroxymethyl side groups that can react with eachother 
(Figure 2B).5 Methylene hydrate has the highest affinity for cysteine, lysine, 
histidine and tyrosine, but also reacts with nucleic acids and lipids.6   
 
Aldehydes cross-link molecules adjacent to each other. For example, soluble 
proteins can cross-link to each other or to cytoskeletal or membrane-associated 
proteins, eventually resulting in a meshwork held together by a multitude of 
aldehyde molecules.2 Glutaraldehyde cross-linking is irreversible and withstands 
acids, urea and heat, while paraformaldehyde cross-linking is reversible.2 In case 
bridging of the hydroxymethylene groups has not yet occurred they can be rapidly 
- 15 -
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returned to their original groups if the paraformaldehyde is washed away. It is 
therefore that the cross-linking capacities of glutaraldehyde are stronger than 
those of paraformaldehyde.2 Besides differences in their cross-linking capacities, 
the penetration rates of glutaraldehyde and paraformaldehyde also differ. 
Glutaraldehyde penetrates generally very poorly in compacts tissues that have 
multiple membrane layers.7 Paraformaldehyde on the other hand penetrates 
about five times faster than glutaraldehyde.7 It is therefore that fixation protocols 
have been designed that combine both aldehyde fixatives. An example of such a 
protocol is the Karnovsky fixative.8 This fixation protocol utilises a relatively low 
percentage of formaldehyde that in theory penetrates fast and temporarily cross-
links structures that are later more permanently stabilised by glutaraldehyde.2, 8  
 
Osmium tetroxide fixation 
Osmium tetroxide contains four double-bonded oxygen molecules and works as a 
secondary fixative by reacting with lipid moieties (Figure 2C). Glutaraldehyde 
followed by osmium tetroxide is considered as a fixation protocol that is capable 
of stabilizing the maximum number of different cell components.2 In addition to 
its fixation capacities, it is widely believed that the unsaturated bonds of fatty 
acids are oxidised by osmium tetroxide, which adds additional density and 











Figure 2: A) chemical structure of glutaraldehyde, B) chemical structures of formaldehyde and 
methylene glycol, C) chemical structure of Osmium tetroxide.  
 
Dehydration and resin embedding 
To cut ultrathin sections from relatively soft biological specimens, specimens need 
to be hardened. Conventionally this is done by infiltrating fixed and dehydrated 
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Dehydration is generally performed upon the gradual replacement of water by 
graded series of dehydrating agents such as ethanol or acetone. After dehydration 
the dehydrants are gradually replaced by resin monomers. These resin monomers 
are in the majority of instances epoxy resins, such as Epon10 and Araldite.11, 12 
Epoxy resins are polyaryl ethers of glycerol bearing terminal epoxy groups (Figure 
3A). To ensure resin polymerisation, three components must be included in the 
resin: (1) the epoxy resin monomer, (2) a hardening agent (for example; 
dodecenyl succinic anhydride (DDSA) (Figure 3B) or nadic methyl anhydride (NMA) 
(Figure 3C)), and (3) an accelerator (for example benzyldimethylamine (BDMA)) 
(Figure 3D). After resin infiltration, resins get cured at 60  C̊. As an alternative to 
epoxy resins, acrylic embedding media such as Lowicryl can be used, which get 
cured at lower temperatures.2, 13  
 
Hardening the sample without resin; the Tokuyasu technique 
TEM samples can also be hardened with rapid freezing. However, this has to occur 
fast and samples need to be cryo-protected in order to prevent ice-crystal 
formation. The most renowned method for freezing samples for TEM analysis is 
the Tokuyasu technique.14 With this strategy biological samples are first aldehyde 
fixed and embedded in gelatine, after which small sample blocks are cut and 
subjected to a sucrose infiltration step that functions as a cryo-protectant. Sample 
blocks are then placed on a metal specimen holder and are rapidly frozen and 















Figure 3: A) Idealised chemical structure of a typical epoxy, B) chemical structure of dodecenyl 
succinic anhydride (DDSA), C) chemical structure of nadic methyl anhydride (NMA), D) chemical 






Once a sample is hardened by one of the above methods, ultrathin sections can 
be obtained. Sectioning of resin embedded samples is performed using a diamond 
knife and an ultramicrotome, and generally involves the following steps; trimming 
or shaping of the specimen block with a glass or diamond knife, cutting of sample 
sections in an ultramicrotome with a diamond knife, retrieving sections and 
placing sections onto a specimen grid holder.2  Sections can vary in size from 30 to 
150 nm. However, the general rule is the thinner the section, the higher the 
resolution.2   Sectioning of frozen samples is known as cryo-ultramicrotomy and 
works along the same principle, with the exception that sectioning is performed at 
-80°C to -140°C and frozen sections are retrieved with a sucrose droplet.14  
 
Staining 
EM images consist of various shades of grey that represent the density differences 
in a specimen; darker shades are areas of the specimen that have greater density, 
whereas brighter areas of the specimen have less density. Since unstained 
biological samples have little density differences it is important to increase the 
image contrast by reacting cellular components with heavy metals.2 Contrast 
enhancement can be established with the secondary fixative osmium tetroxide 
(Figure 2C)15, and with the heavy metal stains lead citrate and uranyl acetate 
(Figure 4A/B). Osmium reacts with the lipid moieties of a specimen and the lead 
ions of lead citrate bind to negatively charged components such as carboxylate 
groups and osmium-reacted areas. Lead citrate staining is therefore commonly 
performed on sample sections that have been osmium-fixed and resin-embedded. 
Uranyl ions react with phosphate and amino groups, thereby staining nucleic acids 
and certain proteins, and are generally used to stain rehydrated cryo-sections.16, 17  
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Biomolecule detection with electron microscopy 
Although TEM enables observations at nanometer-scale resolution, the revealed 
ultrastructures remain uncharacterised. It is therefore that several techniques 
have been developed to label the biomolecules that are present in the EM-
revealed structures. Most commonly colloidal gold particles are used for this 
purpose.18-21 These particles can be functionalised with macromolecules used in 
immunocytochemistry, such as antibodies and protein A,18 and give a punctate 
and precise labelling pattern of the biomolecule of interest (Figure 5).18, 19 Gold 
labelling is generally performed on Tokuyasu cryo-sections as with this technique 
epitopes remain preserved and accessible to the functionalised gold particles.14, 22, 
23  
 
Figure 5: Example of 15 nm immunogold labelling of the endoplasmic reticulum, Endoplasmic 










Besides gold markers oxidizing substrates, such as diamino-benzidine (DAB), are 
also often used to generate localised osmiophilic precipitates which can serve as 
electron dense markers.24 These reporter precipitates can be formed using 
photosensitizing dyes25, 26, peroxidases such as horseradish peroxidase (HRP)24 and 
engineered peroxidase enzymes, such as APEX/APEX2.27 By conjugating the 
photosensitizing dyes/enzymes to specific antibodies or ligands, this approach can 
be used to visualise specific proteins.28, 29 Due to the high penetrability of DAB it 
can be performed prior to sectioning. Moreover, since DAB precipitates are not 
affected by resin embedding, the DAB-labelling approach is commonly applied to 
resin-embedded samples which are generally not susceptible to any on-section 
labelling strategies.2  
 
Correlative Light and Electron Microscopy approaches 
Fluorescent markers can also be used for biomolecule detection in case 
fluorescent microscopy (FM) is combined with EM.30 Specific biomolecules and 
cellular structures can be identified -upon use of a fluorescent marker- with FM, 
after which ultrastructural information about their subcellular location and 
context can be obtained with the EM.30 As a result, one can interpret the 
fluorescent labelling on a complete cell, whereas electron dense markers are too 
small for detection at a low magnification. Over the years many of these 
correlative light and electron microscopy (CLEM) strategies have been reported,30 
which can generally be divided into these two: the ones that combine live-cell FM 
imaging with EM imaging, and those that combine FM and EM imaging of the 
same sample sections.  
 
Correlating live-cell dynamics with EM ultrastructures 
When combining live-cell FM imaging with EM imaging, dynamic processes 
observed with FM can be analysed with ultrastructural detail using the EM.30 Live-
cell CLEM imaging methods basically consist of six steps: 1) the incorporation of a 
fluorescent marker in live cells, 2) live-cell FM imaging, 3) sample preparation for 
EM analysis, 4) ultramicrotomy, 5) EM imaging, 6) correlation of FM and EM 
images.31 An example of this workflow is illustrated in Figure 6. One of the first 
attempts of combining live-cell FM with EM, has been reported by Nakata et al.32 
In this study the subsequent EM imaging of in vivo imaged GFP-tagged plasma 
membrane proteins was demonstrated. Although this strategy attempted to 
image the same cell with both imaging modalities, it did not allow for the 
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identification of the very same cell or region of interest (ROI).32 This problem 
relies in the fact that EM imaging is in need of extra sample preparations and 
ultrathin sectioning; it is therefore very difficult to retrace the originally live-cell 
FM-imaged location with the EM. To this end various methods have been 
reported that focus on the EM retrieval of a ROI that has been imaged with live-
cell microscopy. For example Van Rijnsoever et al. reported the retrieval of a ROI 
by using gridded coverslips.33  
 
Correlating LM and EM from the same sections 
Although strategies have been reported that improve the retrieval of the ROI in 
live cells with EM, it remains problematic to retrieve the exact ROI. It is therefore 
that strategies have been developed to correlate FM and EM images of the same 
sample section, a strategy referred to as on-section CLEM. This strategy does not 
allow for live-cell imaging, but does ensure that the exact same ROI is imaged with 
both imaging modalities. The on-section CLEM workflows generally consist of the 
following six steps: 1) the labelling with of a fluorescent marker in live, fixed or 
sectioned cells, 2) sample preparation for EM analysis, 3) cryo-ultramicrotomy, 4) 
FM imaging, 5) EM imaging, 6) correlation of FM and EM images. An example of 
this workflow is illustrated in Figure 7. The main difference between live-cell CLEM 
and on-section CLEM is that the fluorescence labelling can occur at different 
stages. For example, live or fixed cells can be labelled with a fluorescent reporter 
that remains fluorescent after EM sample preparation and ultrathin sectioning.34 
Another approach is to label the specimen after embedding and ultrathin 
sectioning.35 This can also be applied in sequence to specimens that already 
contain fluorescence labelling, and thus allows for additional labelling steps after 
sample preparation. In general the on-section CLEM strategy is very useful to use 
FM as a map to guide through the sectioned sample, to identify transiently 
transfected cells, and to identify rare structures of interest. Moreover ultrathin 
sections (typically 50-80 nm) yield very sharp fluorescence images that lack the z-
axis blur.36 Correlation of LM and FM in case of on-section CLEM is facilitated by 
the use of fluorescent/electron-dense fiducials. These fiducials can be imaged 









Figure 6: Schematic representation of a CLEM workflow that combines live-cell imaging with EM.  
 
 
Figure 7: Schematic representation of an on-section CLEM workflow.  
 
Conclusion 
To ensure the TEM analysis of large biological samples, samples need to be fixed, 
dehydrated, hardened, sectioned and stained. These procedures can be varied 
upon the research questions to be answered, and as a result many protocols have 
been developed. For example, research questions in need of the best possible 
ultrastructural preservation usually involve vigorous cross-linking with 
glutaraldehyde and resin embedding, whereas mild aldehyde fixation and cryo-
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sectioning is performed when (immuno-)labelling of the EM-revealed structures is 
desired.  
 
Labelling of biological samples for TEM analysis is traditionally performed with 
electron-dense markers such as colloidal gold or DAB. Alternatively, specimens 
are imaged with both FM and the EM, followed by correlation of the acquired 
data sets. This strategy referred to as CLEM is especially useful for the localisation 
of rare events, and can be applied in combination with a wide variety of 
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The Potential of Bioorthogonal Chemistry for  










Correlative light and electron microscopy (CLEM) is an imaging technique that 
combines the virtues of light microscopy (LM) with those of electron microscopy 
(EM). With this technique specific molecular and cellular structures in a cell can be 
identified with LM, after which ultrastructural information about their subcellular 
location and context can be obtained. CLEM studies that involve fluorescence 
microscopy may benefit from fluorescent markers that can be attached to 
molecules of interest to allow their identification and localisation. To date, this 
has most readily been done by fluorescent fusion proteins, by fluorescent 
antibody labelling or by the chemical modification of a protein with a fluorescent 
detection group.1-3 As well as these fluorescent detection moieties, structures 
must be present in the CLEM sample that are both EM- and LM- detectable in 
order to correlate (overlay) the LM image with the EM image. Examples of such 
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EM/LM detectable structures are fluorescently-labelled cellular structures that are 
suitable to be identified by EM through their distinct morphology (e.g. stained 
nuclei), or fluorescently-labelled electron-dense particles (e.g. fluorescent 
microspheres).1-4 
 
The above-mentioned labelling approaches have been very successfully applied to 
CLEM imaging of specific proteins in their cellular context. However, they carry 
some limitations. First, the use of fluorescent fusion proteins requires genetic 
manipulation of the cell, which can be difficult and can affect the function of the 
protein of interest.5 An alternative to genetic manipulation is antibody labelling. 
However, for specimens prepared for CLEM, antibody labelling is an elaborate 
procedure, of which the success rate is notoriously low due to lack of functional 
antibodies.6 Finally, all these labelling approaches do not readily allow imaging of 
non-templated biomolecules, such as glycans and lipids.  
  
Bioorthogonal chemistry is a powerful new labelling tool that circumvents the 
disadvantages mentioned above and allows for the imaging of a wide range of 
biomolecules. Its mechanism7 relies on the introduction of a small abiotic chemical 
group (one that is non-reactive with other chemical functionalities found in the 
cell) into a biomolecule of interest which can be specifically reacted with a 
detection moiety using a so-called ‘bioorthogonal’ chemical reaction: a reaction of 
the tag with a detectable group that is essentially background free in biological 
systems (Fig. 1A).8 As this labelling strategy makes use of a small chemical group 
to tag a biomolecule of interest it minimally interferes with the structure of the 
labelled biomolecule and as such minimally affects cellular biochemistry.9 Since 
the initial development of the Keto-oxime and Staudinger-Bertozzi-ligations, 
bioorthogonal labelling chemistry has evolved rapidly. Currently, a wide-ranging 
chemical toolkit is available of both tags for incorporation into biomolecules and 
reactions for subsequent labelling of these tags.10 The choice of tag and 
modification chemistry can therefore be optimised and tailored for the specific 
biological hypothesis.7 
 
The introduction of a bioorthogonal tag into a biomolecule of interest occurs most 
readily by the metabolic incorporation of a tagged biomolecule building block. 
One of the approaches that exemplifies the metabolic incorporation strategy was 
reported by  Saxon et al.11 They synthesised a cell-permeable azide-tagged N-
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acetylmannosamine analogue (Ac4ManNAz) which was administered to 
mammalian cells during cell culture.12 Inside these cells the acetyl groups were 
removed from Ac4ManNAz, after which it was passed on to the steps of the sialic 
acid biosynthetic pathway where it was converted to N-azidoacetyl sialic acid 
(SiaNAz). After conversion to the nucleotide sugar CMP-SiaNAz, SiaNAz is 
incorporated into various glycoconjugates by sialyltransferase enzymes. With this 
approach Saxon et al. produced cells containing azide-tagged sialoglycans and 
visualised these using the Staudinger-Bertozzi reaction (Fig. 1B).   
 
Since this first inception, the applications and classes of biomolecules that can be 
labelled with this approach have expanded rapidly. For instance, Salic & 
Mitchinson nicely demonstrated that bioorthogonal tags can be incorporated into 
newly synthesised DNA of both cultured cells and mouse tissues after metabolic 
incorporation of the tagged nucleic acid 5-ethynyl-2'-deoxyuridine.13 An additional 
example is the metabolic incorporation of bioorthogonal tags into lipids in order 
to study protein lipidation and lipid trafficking (thoroughly reviewed in 14). 
Likewise, metabolic incorporation of bioorthogonal chemical tags has been 
reported for proteins.15 Kiick et al. showed the incorporation of bioorthogonal 
tags in the proteome of Escherichia coli (E. coli) cells upon addition of the tagged 
amino acid azidohomoalanine. They showed that azidohomoalanine could be 
incorporated at sites where the amino acid methionine naturally resides. 
Hatzenpichler et al. showed that tagging of proteins using this abiotic amino acid 
is a successful approach to study newly synthesised proteins in individual 
microorganisms within environmental samples.9 In addition to the proteome-wide 
metabolic incorporation of bioorthogonal tags, single proteins can also be 
modified by using amber codon suppression (reviewed in 16). Although genetic 
modification is needed for this approach –with the same downsides as other 
genetic techniques– it is a great addition to the bioorthogonal toolkit. Attachment 
of abiotic tags to covalent enzyme inhibitors even allows to selective visualise 
active populations of enzymes in a complex mixture.17-19 Moreover, it can be 
applied to the tagging of biomolecules in living multicellular organisms, such as C. 
elegans20, zebrafish (Danio rerio) 21, 22 and mice (Mus musculus)23.  
 
There are now also numerous bioorthogonal reactions available for labelling these 
tags (thoroughly reviewed in 24 and 10). Examples of the most often used labelling 
strategies are illustrated in Fig. 1C-F. The copper-catalysed Huisgen cycloaddition 
- 29 -
Chapter 2 
(ccHc) is well-known for its high reaction rate and selectivity and is often used on 
fixed sample material, as copper is toxic to cells (Fig. 1C).25 The strain-promoted 
cycloaddition reaction is a faster alternative of the Staudinger ligation and allows 
in vivo labelling as there is no need of copper catalysis during this reaction (Fig. 
1D).26 The inverse electron-demand Diels-Alder cycloaddition is a fast 
bioorthogonal reaction that does not require catalysis. An example of such a 
reaction is the cycloaddition of s-tetrazine and trans-cyclooctene derivatives (Fig. 
1E).27 It is also possible to use photo-activatable chemical groups for so-called 
‘photoclick’-reactions. Nitrile imine mediated [1,3]-dipolar cycloaddition reaction 
and has been employed to selectively functionalise an alkene genetically encoded 
in a protein inside E. coli cells.28 The reaction procedure was reported to be simple, 
straightforward, and nontoxic to E. coli cells (Fig. 1F). This variety in labelling 
strategies and chemical reactions highlights the versatility of the approach as it 
can be altered upon experimental settings. It is even possible to ‘multiplex’ 
different bioorthogonal reactions;29 i.e. to first label one class of biomolecules (in 
this case a proteasome subunit) using one bioorthogonal reaction, then perform 
an additional bioorthogonal reaction on a second class and a third reaction on a 
third class of bioorthogonal groups. This approach shows that the reactions are 
not just bioorthogonal, but also mutually orthogonal to one another. 
 
Bioorthogonal chemistry is anticipated to become a powerful and useful addition 
to the CLEM labelling toolkit. It would allow the imaging of non-protein 
biomolecules and it precludes the need for genetic tagging and antibody labelling. 
Furthermore, the fate of biomolecules labelled by these approaches can even be 
monitored during the degradation process. For example, a protein labelled with 
bioorthogonal amino acids can be imaged, even when it is proteolytically 
degraded, as  - unlike reporter proteins – the tags survive this catabolic pathway.30 
At the start of this project, bioorthogonal reactions had not been combined with 
CLEM-imaging. This is surprising, since fluorescent imaging of bioorthogonal tags 
has become commonplace over the last decade and a half.7 In this review, some 
of the inroads that have been made towards the CLEM-imaging of bioorthogonal 
reactions will be highlighted. 
 
Bioorthogonal labelling for CLEM imaging  
To allow EM imaging of bioorthogonal tags an electron-dense group is required 
that can be introduced using a bioorthogonal reaction. The most commonly used 
EM-detectable groups are gold nano-particles (GNPs).31 However, GNPs in 
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combination with bioorthogonal labelling have not been explored for this purpose. 
This is remarkable, since the inverse use of bioorthogonal chemistry – to 
synthesise protein/DNA-modified gold particles - has been reported.32, 33 In these 
studies, no change in GNP size was observed and hydrophobic, organometallic 
and hydrophilic moieties could be introduced onto the particles. Brennan et al.34 
used a similar biochemical approach to produce biomolecule-modified gold 
particles. They first produced azide-modified gold particles and 4-pentynoic acid 
modified lipase and reacted the two using a copper (II) catalyst with ascorbate 
reducing agent to generate the active Cu(I) species in situ. Under reducing 
conditions the thiol-gold linkage appeared stable and gold particles modified with 
lipase were observed. These examples indicate that GNPs have the potential to be 






Figure 1: Bioorthogonal chemistry for imaging. A) General approach: a biologically inert group is 
incorporated into a biomolecule class in a living cell and selectively visualised using chemistry 
specific for this bioorthogonal group; B) An azide-labelled N-acetylmannosamine analogue is 
converted to CMP-sialic acid in vivo. Azido-sialic is then incorporated into the nascent glycoproteins. 
C-F) Recently applied bioorthogonal reactions for imaging; C) the copper-catalysed Huisgen 
cycloaddition 25, D) the strain-promoted cycloaddition 26, E) the inverse electron-demand Diels-Alder 
cycloaddition 27, F) or the photoclick reaction 28. 
 
Instead of electron-dense EM-detectable particles, bioorthogonal fluorophore 
introduction could also be used for EM-imaging; namely in combination with 
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CLEM, especially considering that fluorescent bioorthogonal labelling strategies 
are very well established in the field. Additionally, to perform CLEM with this 
particular strategy, detectable moieties are required that are visible in both 
imaging modalities (e.g. fluorescent electron-dense nano- or micro-particles).  
 
One approach to circumvent this would be to directly react the bioorthogonal tags 
with such electron-dense fluorophores. Quantum dots (Qdots) are suitable 
candidates for this purpose.35 As with GNP modification, significant development 
has gone into the modification of Qdots with biomolecules using bioorthogonal 
strategies. Again, they have not yet been used for introducing these fluorophores 
for CLEM. In the case of CLEM labelling, one difficulty with the modification of 
Qdots using ‘classic’ copper-catalysed Huisgen reaction (Fig. 1C) is fluorescence 
quenching.36 Fluorescence quenching was circumvented by using either the strain-
promoted [3+2]-cycloaddition reaction (Fig. 1D)36, or the tetrazine-norbornene 
inverse electron demand Diels-Alder reaction (Fig. 1E).37 In the former reaction, 
cyclooctyne-modified cadmium selenide/zinc sulphide (CdSe/ZnS) core-shell 
Qdots were modified with cyclooctyne groups and as such used to image the 
presence of azide-containing sugars on the surface of cultured CHO cells, 
analogous to the work performed by the Bertozzi group. However, in these 
experiments no CLEM was performed. Zhang et al.38 recently used a similar 
approach to image the intracellular presence of viruses. CdSe/ZnS-Qdots were 
modified with an azide-containing outer coating. These particles were then 
reacted with dibenzocyclooctyne-modified viruses that had been used to infect 
GFP-expressing A549 cells. This approach allowed the imaging of viral infection in 
these cells with good selectively. Recently, the same group published the in vivo 
imaging of virus infection using a near-infrared Qdot variant39, highlighting the 
power of this approach. 
 
A second alternative approach by which the subcellular location of fluorophores 
can be made EM-visible is by photoconversion of diaminobenzidine (DAB).40 This 
approach uses fluorophores to photooxidise DAB, which results in precipitates 
after reaction with osmium. These precipitate are electron-dense and therefore 
EM-detectable. Such fluorophores are readily available as detecting agents for 
bioorthogonal reactions and numerous examples exist of the use of these to label 
biomolecules. However, again no examples have been reported of the approach 
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where first the fluorophore is used to image a bioorthogonal label followed by 
photoconversion of DAB to allow for EM-imaging.  
 
A final example of an approach that has great potential for CLEM imaging of 
enzyme activities is the use of an aggregating probe. Ye et al.41 reported the use of 
a probe that upon cleavage by the apoptosis-related caspases 3 or 7 cyclises and 
precipitates to form insoluble fluorescent nano-aggregates. Rather than imaging 
these aggregates by CLEM, the authors imaged them by super-resolution 
microscopy and conventional confocal microscopy. They also showed that these 
probes could be applied to the in vivo imaging of tumour apoptosis after 
treatment with doxorubicin.  
  
Conclusion 
The examples and strategies discussed here highlight the power of bioorthogonal 
chemistry for the labelling of biomolecules in a cellular context. Bioorthogonal 
chemistry has not been explored for CLEM imaging, although many inroads have 
been made. It is anticipated that bioorthogonal chemistry will enable CLEM 
imaging of molecules for which the current toolkit is not amenable, such as non-
genetically templated biomolecules, temporal subpopulations of proteins (those 
expressed in a given time window), or the imaging of enzymatically active 
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Bioorthogonal chemistry is a powerful tool to image (sub)-populations of 
biomolecules in complex biological systems. Its mechanism relies on the 
introduction of a physiologically-inert tag into a biomolecule of interest that can 
be reacted with a detection moiety using a chemical reaction selective solely for 
this chemical moiety.1 The small size of the chemical tag, which minimally 
interferes with cellular biochemistry and the broad scope of the labelling 
strategies make this method a valuable part of the biochemist’s toolkit.2, 3 It has 
proven especially powerful for the labelling of nongenetically-templated 
biomolecules such as glycans4, lipids5, 6, peptidoglycans7, 8 and even active sub-
populations of proteins using activity-based probes.9, 10 Moreover, the approach is 
amenable to labelling biomolecules in a wide range of cell types and species 
spanning the prokaryotes, eukaryotes and metazoans.11  
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The most commonly used detection techniques for the imaging of bioorthogonal 
handles are the reaction of these moieties with biotin, FLAG tags, or with a 
fluorophore for direct visualisation using confocal fluorescence microcopy.2 
However, the main limitations of all these imaging approaches is the lack of 
resolution and the lack of information regarding the cellular environment in which 
these bioorthogonally-labelled molecules reside. Attempts to address this with 
super resolution microscopy have been reported12, but this technique only 
provides the localisation information of the labelled molecule to very high 
accuracy but does not provide ultrastructural information of the cellular context 
of the handle.  
 
Electron microscopy (EM) on the other hand, allows to map cellular 
ultrastructures at nanometer-scale resolution,13 but the identification of specific 
biomolecules using conventional EM-approaches can be cumbersome.14 Most 
readily the identification of  biomolecules within EM imaged specimens is 
established upon colloidal gold labelling. Colloidal gold can be functionalised with 
macromolecules used in immunocytochemistry, such as protein A, antibodies, 
lectins or even polysaccharides.15 It can be easily visualised with the electron 
microscope due to its electron-dense character and gives a punctate and precise 
labelling pattern. These features make them favourable for the localisation of 
biomolecules within structures studied at nanometer-scale resolution. 
Additionally, their particulate nature allows the labelling to be quantified with the 
possibility of estimating the amount of a particular protein molecule in a given 
structure.15, 16 
 
Besides colloidal gold markers, which are directly visible in the EM, one can also 
decide to use fluorescent markers;17 an approach known as CLEM (correlative 
light and electron microscopy). It combines the strengths of both light microscopy 
(LM) and EM imaging. For example, an image acquired with fluorescence 
microscopy (whereby fluorescently labelled biomolecules  are identified) is 
overlaid on an EM image, which provides ultrastructural context to the 
fluorescent signal.18 To date, CLEM has been used successfully to image GFP-
fusion proteins, biomolecules labelled with immunofluorescence,19, 20 or for the 
detection of small molecule fluorophores.19-22  
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These labelling techniques have, however, not been exploited to localise 
bioorthogonal groups in biological samples. One problem may be partial loss of 
the bioorthogonal functional groups during the (often harsh) conditions required 
for resin embedding of the samples (e.g. heating in presence of epoxide during 
Epon-embedding or exposure to radical polymerisation during Lowicryl-
embedding).23 This, combined with the fact that the yield of the bioorthogonal 
detection reaction must be very high and essentially background-free to allow 
detection of the label in ultrathin sections, may have prevented the application of 
this imaging modality to the detection of bioorthogonal functionalities in 
biological samples to date. 
 
In this chapter the method development of EM compatible bioorthogonal 
labelling approaches are presented. These approaches build further on the 
Tokuyasu technique commonly used for on-section immuno-labelling21, 24 which 
uses vitrification of cryoprotected, aldehyde-fixed samples and subsequent 
cryosectioning. The first method presented makes use of gold labelling, allowing 
the direct EM-visualisation of bioorthogonal groups in a biological sample. The 
second approach is a CLEM-based approach. This approach uses bioorthogonal 
fluorophore labelling and fluorescence microscopy prior to EM contrast 
enhancement and EM imaging of the same section. These methods were 
developed using the model bacterium Escherichia coli (E. coli). In this bacterium 
bioorthogonal azide handles25, 26 can be readily incorporated by replacement of 
the methionine (Met) with azidohomoalanine (Aha) in the Met auxotrophic strain 
B834(DE3).27, 28  
 
Results 
Aha-incorporation in E.coli B834(DE3) was optimised with respect to cell viability 
and amount of incorporation. Culturing E. coli B834(DE3) for > 1 hour in the 
presence of 4 mM Aha (azido-E. coli) resulted in reduced outgrowth in comparison 
to cultures grown in the presence of Met (Figure 1). As well as showing reduced 
outgrowth, inclusion bodies were found to be formed at these time points (Figure 
2), suggesting negative effects on protein folding upon prolonged exposure to 
Aha.29 Labelling for 1 h in the presence of 4 mM Aha gave a robust signal 
throughout the E. coli proteome and showed minimal inhibition of viability 
(supported by30; Figure 3). These conditions (1 h, 4 mM Aha) were used for all 





Next it was tested whether the azido-E. coli B834(DE3) cells could be labelled with 
gold particles. Initial attempts aiming to directly conjugate gold particles to the 
bioorthogonal groups proved unsuccessful. But a labelling method based on a 
two-step strategy did prove fruitful: bioorthogonal copper-catalysed Huisgen 
cycloaddition (ccHc) was performed with a fluorophore,31-33 followed by 
immunogold labelling against the fluorophore (Figure 4A). This two-step gold 
labelling strategy was tested on the surface of whole mount E. coli cells.  
 
Figure 1: Outgrowth of E. coli B834(DE3) that were cultured in the presence of Aha (n=2):  E. coli 
B834(DE3) cells were grown to an OD600 of 0.3-0.5.  Cultures were then incubated with 4 mM Aha 
for either 30(A), 60(B) or 120 minutes (C). Cells were then collected and left to grow in 
LB medium. OD600 was measured at indicated time points.  Cultures grown in the presence of Aha 
for t > 60 minutes showed severe effects on the outgrowth.  
 
To ensure a high density of bioorthogonally labelled proteins on the surface of 
E. coli, E. coli B834(DE3) was transformed with the uncleavable autotransporter 
protein hemoglobin protease (Hbp).34, 35 Upon incorporation of Aha in both the 
Hbp(Δβ-cleav) expressing and the Wild type (Wt) bacteria, the bioorthogonal gold 
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labelling of the Hbp(Δβ-cleav)-transformed E. coli was more pronounced 
compared to Wt E. coli, demonstrating the presence of bioorthogonally labelled 
Hbp(Δβ-cleav) (Figure 4B). Expression of the Hbp(Δβ-cleav) in the presence of 4 








































Figure 2 : Inclusion body formation in E. coli B834(DE3) that were grown in the presence of Aha.  
E. coli B834(DE3) cells were grown to an OD600 of 0.3-0.5. Cultures were then incubated with 
4 mM Aha (A-C) or 4 mM Met (D-F). After 30 (A, D), 60 (B, E) and 120 minutes (C, F) cells were 
harvested, fixed with 2% PFA and imaged with the electron microscope. Inclusion bodies were 
present in E. coli cells cultured  for 120 minutes in the presence of 4 mM Aha (C). Inclusion body is 
indicated with an arrow. Scale bar 500 nm. 
A 








Figure 3: Aha incorporation in E. coli B834(DE3): (A) Fluorescence gel of AlexaFluor-488 alkyne-
labelled E. coli cells grown in the presence of the indicated concentrations of Aha and Met. 
Maximal label incorporation was seen after 60 minutes in absence of Met and in presence of 4 mM 













Electron Microscopy of Bioorthogonally-Labelled Biomolecules 
 
 
Figure 4: A) Schematic overview of bioorthogonal gold labelling strategy. Azido-E. coli B834(DE3) 
cells are surface-labelled with AlexaFluor-488 alkyne (green), after which gold particle labelling is 
performed using a rabbit anti-AlexaFluor-488 binding step. B) Bioorthogonal gold surface-labelling of 
Hbp (Δβ-cleav)-expressing and Wild type (Wt) E. coli B834(DE3) bacteria cultured in the presence of 

























Figure 5 : Coomassie-stained SDS-PAGE gel of E. coli B834(DE3) cells with/without Hbp(Δβ-cleav) 
expression and grown in the presence of either 4 mM Aha or 4 mM Met.  
 
To ensure the analysis of bioorthogonal labelling on ultrastructures, it was next 
tested whether the bioorthogonal tagged E. coli B834(DE3) cells could be 
specifically gold-labelled after Tokuyasu sample preparation and cryosectioning.36 
To this end a mixture of the bioorthogonal tagged azido-E. coli cells and E. coli 
control cells (grown in the presence of Met) was subjected to Tokuyasu sample 
preparation. E. coli cells (Aha and Met treated) were fixed for 24h in 0.1 M 
phosphate buffer containing  2% paraformaldehyde (PFA). Labelling with the 
bioorthogonal gold labelling method shows that the azido-E. coli bacteria could be 
labelled and detected within a mixture with Met control cells (Figure 6). The ccHc 
reaction has sufficient signal-to-noise ratio for detection of azides even in 
ultrathin sections. Fixation of the bacteria with 2% PFA supplemented with 0.2% 
glutaraldehyde (GA) gave undesired background labelling, which is clearly visible 
on the Met treated control cells (Figure 7). This background was also present on 
whole mount E. coli cells upon fixation with 0.2% GA (Figure 7). All following 
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Figure 6: EM image of azido-E. coli mixed 1:25 with Met-treated E. coli. After mixing, cells were fixed 
with 2% PFA and subjected to Tokuyasu sample preparation (including gelatin embedding and 
sucrose infiltration) prior to cryosectioning into 75 nm sections. An on-section ccHc reaction was 
performed to react azido-E. coli cells  with AlexaFluor-488 alkyne. AlexaFluor-488 was then labelled 
with 15 nm protein A coated gold particles using an anti-AlexaFluor-488 antibody. Arrows indicate 













Figure 7 : Upper panel; Azido-E. coli and Met-treated E. coli fixed with either 2% PFA or 2% PFA 
supplemented with 0.2% GA and labelled with bioorthogonal gold labelling strategy. Scale bar 1 
µm. Lower panel; bioorthogonal gold surface-labelling of Hbp(Δβ-cleav) expressing E. coli B834(DE3) 
bacteria cultured in the presence of either 4 mM Aha or 4 mM Met and fixed with either 2% PFA or 
2% PFA supplemented with 0.2% GA. Scale bars 500 nm. 
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It was then verified whether bioorthogonal labels could be additionally detected 
in an EM setting using a CLEM approach.  To this end a strategy was developed 
that is outlined in Figure 8A. Mixed azido-E. coli and Met-incubated E. coli were 
cryosectioned and transferred to a TetraSpeck bead-containing EM grid and were 
labelled with AlexaFluor-488-alkyne using a ccHc-reaction. These sections were 
then imaged with the confocal microscope and were embedded in methyl 
cellulose with uranyl acetate and subjected to EM imaging. Correlation of the 
confocal- and EM-images was performed using TetraSpeck beads37 as fiducials 
(Figure 8A and 9). Results show that CLEM imaging of azides using bioorthogonal 
labelling is selective and that the ccHc reaction has sufficient signal-to-noise ratio 
for the detection of fluorescently-labelled azides in ultrathin sections (Figure 8B).  
 
Figure 8: A) Schematic overview of bioorthogonal labelling strategy for CLEM-imaging. Azido 
and unlabelled E. coli were mixed in non-equal ratio (1:25). After Tokuyasu sample preparation and 
cryosectioning into 75 nm sections, a ccHc-reaction with AlexaFluor-488 was performed. B) CLEM-
image of the above experiment. Green: AlexaFluor-488 label. Dotted circles: signal from the 100 nm 








Figure 9: CLEM image of azido-E. coli B834(DE3) in a mixture with unlabelled E. coli B834(DE3) (A) 
Confocal microscopy image of azido-E. coli B834(DE3) in a mixture with unlabelled E. coli 
B834(DE3). Green: AlexaFluor-488 and 100 nm TetraSpeck beads, Yellow = 100 nm Tetraspeck 
bead. (B) EM image of azido-E. coli B834(DE3) in a mixture with unlabelled E. coli B834(DE3). (C) 
CLEM image obtained from figure A and B using section shape for correlation. (D) Detail from C. 
Green: AlexaFluor-488 alkyne and 100 nm TetraSpeck beads, Yellow 100 nm Tetraspeck beads. 
Tetraspeck beads were used for correlation. (E) Detail from D. Green: AlexaFluor-488 alkyne and 
100 nm TetraSpeck beads, Yellow 100 nm Tetraspeck beads (indicated with circles and arrows). 
Tetraspeck beads were used for correlation. Scale bar 1 μM.  
 
Conclusion 
Two methods were developed for the EM detection of intracellular bioorthogonal 
groups on ultrathin cryosections. The first method is a bioorthogonal gold 
labelling strategy that allows for the direct detection of gold-labelled 
bioorthogonal tags in the EM. The second method uses CLEM for the detection 
of bioorthogonal labels in cryosectioned  biological samples. This approach 
provides facile detection of bioorthogonal tags with fluorescence microscopy 
and gives ultrastructural information on the cellular location of these tags 
using EM. Both methods show that bioorthogonal labelling can be used to 
A B C 
D E 
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selectively label and localise the presence of bioorthogonal tags with EM in a non-
homogenous sample of tagged and untagged E. coli.  
 
Since a wide variety of both templated and non-templated biomolecules can be 
modified by this method, it is foreseen that these labelling stratagies can be 
applied to address a wide range of research questions, which would benefit from 
the combination of these bioorthogonal labels and the ultrastructural context 
provided by EM. A final advantage and challenge would be to image biomolecules 
in organisms for which genetic modification is not an option, such as many 
bacterial and viral pathogens, which could lead to new insights regarding 
infectivity and clearance of these organisms by host cells. Furthermore, the 
stability of azides38 to intracellular conditions would allow imaging of events long 




























E. coli culturing conditions and growth measurements  
E. coli B834(DE3) bacteria were grown overnight at 37°C in Lysogeny Broth (LB) 
medium. The following day cultures were diluted 1:50 in LB medium and grown at 
37°C untill an OD600 between 0.3-0.5 was reached. Subsequently cells were 
collected and resuspended in Selenomet medium (Molecular Dimensions) and 
supplemented with different concentrations of either Aha (Bachem) or Met 
(Sigma-Aldrich). After 30 minutes, 1 h, 2 h and 3 h OD600 were measured and cells 
were collected by centrifugation (13,000 x g for 1 minute) for further analysis. To 
monitor the outgrowth of E. coli cells that were cultured in the presence of 
Aha/Met, cells were collected by centrifugation (13,000 x g for 1 minute) at the 
indicated time points, after which Aha/Met-containing medium was replaced for 
LB medium and OD600 measurements were performed.  
 
E. coli B834(DE3)Hbp(∆β-cleav) bacteria were grown overnight at 37°C in LB 
medium supplemented with chloramphenicol (cam) (f.c. 30 µg/ml). The following 
day cultures were diluted 1:50 in LB medium with cam (f.c. 30 µg/ml) and grown 
at 37°C untill an OD600 between 0.3-0.5 was reached. Subsequently cells were 
collected and resuspended in Selenomet medium (Molecular Dimensions) and 
supplemented with either 4 mM Aha (Bachem) or 4 mM Met (Sigma-Aldrich). 
Expression of Hbp∆β-cleav was induced by addition of 1 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG, Sigma-Aldrich). After 2 h of induction cells were 
collected by centrifugation (13,000 x g for 1 minute) for further analysis.  
 
Inclusion body analysis 
At the indicated time points E. coli cells were fixed for 2 h with 2% PFA in 0.1 M 
phosphate buffer.  The fixed cells were harvested by centrifugation (13,000 x g for 
1 minute) and resuspended in PBS. Formvar carbon-coated copper grids were 
floated on small drops of fixed E. coli cells for 5 minutes at room temperature. 
Grids were then washed on 3 drops of PBS and 10 drops of aquadest. Cells were 




At the indicated time points E. coli B834(DE3) cells were collected and lysed with 
lysis buffer (50 mM HEPES pH 7.3, 150 mM NaCl and 1% NP-40) and incubated on 
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ice for 1 h. Subsequently protein concentrations were determined with a Quibit 
2.0 fluorimeter (Life Technologies), after which 20 µg of the protein was 
incubated for 1 h with ccHc-cocktail (0.1 M HEPES pH 7.3, 1 mM CuSO4, 10 mM 
sodium ascorbate, 1 mM THPTA ligand, 10 mM amino-guanidine, 5 µM 
AlexaFluor-488 alkyne (Invitrogen)). Samples were then resuspended in 4x SDS 
Sample buffer (250 mM Tris.HCl pH 6.8, 8% w/v SDS, 40% glycerol, 0.04% w/v 
bromophenol blue, 5% 2-mercaptoethanol) and incubated at 100°C for 5 minutes. 
After  the  samples  were  run  through a  Hamilton syringe  multiple  times  to  
shear genomic DNA, samples were subjected to SDS-PAGE. Gels were then 
directly imaged with a Biorad Universal Hood III for in-gel visualisation of 
fluorescent labelling. As a loading control gels were stained with Coomassie 
Brilliant Blue. PageRuler Plus Prestained Protein Ladder (Thermo Scientific) was 
used as a protein standard. 
 
At the indicated time points E. coli B834(DE3)Hbp(∆β-cleav) cells were collected 
and lysed with lysis buffer (50 mM HEPES pH 7.3, 150 mM NaCL and 1% NP-40) 
and incubated on ice for 1 h. Subsequently protein concentrations were 
determined with a Quibit 2.0 fluorimeter (Life Technologies). Samples were then 
resuspended in 4x SDS Sample buffer (250 mM Tris.HCl pH 6.8, 8% w/v SDS, 40% 
glycerol, 0.04% w/v bromophenol blue, 5% 2-mercaptoethanol) and incubated at 
100°C for 5 minutes. After  the  samples  were  run  through a  Hamilton syringe  
multiple  times  to  shear  genomic DNA, samples were subjected to SDS-PAGE. 
Approximately 20 µg protein was loaded per lane. Gels were then stained with 
Coomassie Brilliant Blue. PageRuler Plus Prestained Protein Ladder (Thermo 
Scientific) was used as a protein standard. 
 
Bioorthogonal gold labelling on whole mount E. coli B834(DE3)  
At the indicated time points E. coli B834(DE3)wt and E. coli B834(DE3)Hbp∆β-cleav 
cells were collected and resuspended in either 4% PFA in 0.1 M phosphate buffer 
or 4% PFA, 0.2% GA in 0.1 M phosphate buffer for 1 h at room temperature. The 
fixed cells were harvested by centrifugation (13,000 x g for 1 minute), 
resuspended in storage solution (0.5% PFA in 0.1 M phosphate buffer) and kept at 
4°C until further analysis. 
 
Fixed E. coli cell pellets, containing ~1 OD600 were resuspended in blocking buffer 





M HEPES pH 7.3) and blocked for 15 minutes. Subsequently cells were collected 
by centrifugation (13,000 x g for 1 minute) and resuspended in click cocktail (0.1 
M HEPES pH 7.3, 1 mM CuSO4, 10 mM sodium ascorbate, 1 mM THPTA ligand, 10 
mM amino-guanidine, 5 µM AlexaFluor-488 alkyne (Invitrogen)). The cells were 
incubated for 1 h with the click cocktail, then washed 3 times with HEPES 0.1 M 
pH 7.3. Subsequently Formvar carbon-coated copper grids were floated on small 
drops of the fluorescently-click-labelled E. coli cells for 5 minutes at room 
temperature. Grids were then washed on 3 drops of PBS and blocked with 1% BSA 
in PBS for 15 minutes. Next, the grids were incubated for 1 h with an AlexaFluor-
488 antibody diluted in PBS supplemented with 1% BSA. After 5 washes with PBS, 
the antibodies were probed with protein A conjugated to 15 nm gold (PAG; CMC, 
Utrecht University). Labellings were imaged with an Tecnai 12 transmission 
electron microscope (FEI) at 120 kV acceleration voltage.  
 
Preparation of cryosections 
Samples were prepared for cryosectioning as described elsewhere.39 Briefly, E. coli 
cells were fixed for 24 h in freshly prepared 2% PFA in 0.1 M phosphate buffer 
with or without 0.2% GA. Fixed cells were embedded in 12% gelatin (type A, 
bloom 300, Sigma Aldrich) and cut with a razor blade into 0.5 mm3 cubes. The 
sample blocks were infiltrated in phosphate buffer containing 2.3 M sucrose for 
3 h. Sucrose-infiltrated sample blocks were mounted on aluminium pins and 
plunged in liquid nitrogen. The frozen samples were stored under liquid nitrogen. 
 
Ultrathin E.coli cell sections of 75 nm were obtained as described elsewhere.39 
Briefly, the frozen sample was mounted in a cryo-ultramicrotome (Leica). The 
sample was trimmed to yield a squared block with a front face of about 300 x 250 
μm (Diatome trimming tool). Using a diamond knife (Diatome) and antistatic 
devise (Leica) a ribbon of 75 nm thick sections was produced that was retrieved 
from the cryo-chamber with a droplet of 1.15 M sucrose containing 1% 
methylcellulose. Obtained sections were transferred to a specimen grid previously 
coated with formvar and carbon. In case of CLEM imaging, grids were additionally 
coated as indicated with 100 nm TetraSpeck beads (Life Technologies). 
 
Bioorthogonal gold labelling on cryosections 
Sections were labelled as follows: thawed cryosections on an EM grid were left for 
30 minutes on the surface of 2% gelatin in phosphate buffer at 37°C. Subsequently, 
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grids were incubated on drops of PBS/glycine and PBS/glycine containing 1% BSA. 
Grids were then incubated on top of the ccHc- cocktail (0.1 M HEPES pH 7.3, 1 
mM CuSO4, 10 mM sodium ascorbate, 1 mM THPTA ligand, 10 mM amino-
guanidine, 5 µM AlexaFluor-488 alkyne (Invitrogen) for 1 h and washed 6 times 
with PBS. Then the grids were blocked again with PBS/glycine containing 1% BSA 
after which the grids were incubated for 1 h with PBS/glycine 1% BSA 
supplemented with an AlexaFluor-488 antibody (Invitrogen). After washing with 
PBS/glycine and blocking with PBS/glycine 0.1% BSA, grids were incubated for 20 
minutes on PBS/glycine 1% BSA supplemented with 15 nm PAG (CMC, Utrecht 
University). Grids were then washed with PBS, and washed 10 times with 
aquadest, after which they were incubated for 5 minutes on droplets of 
uranylacetate/methylcellulose. Excessive uranylacetate/methylcellulose was 
blotted away and grids were dried to air. Labellings were imaged with a Tecnai 12 
Biotwin transmission electron microscope (FEI) at 120 kV acceleration voltage. 
 
Bioorthogonal fluorophore labelling on cryosections 
Sections were labelled as follows: thawed cryosections on an EM grid were left for 
30 minutes on the surface of 2% gelatin in phosphate buffer at 37°C. Subsequently 
grids were incubated on drops of PBS/glycine and PBS/glycine containing 1% BSA. 
Grids were then incubated on top of the ccHc-cocktail (0.1 M HEPES pH 7.3, 1 mM 
CuSO4, 10 mM sodium ascorbate, 1 mM THPTA ligand, 10 mM amino-guanidine, 5 
µM AlexaFluor-488 alkyne (Invitrogen) for 1 h and washed 6 times with PBS and 
10 times with aquadest.  
 
Microscopy and correlation 
The CLEM approach used was adapted from Vicidomini et al.21 Grids containing 
the sample sections were washed with 50% glycerol and placed on glass slides 
(pre- cleaned with 100% ethanol). Grids were then covered with a small drop of 
50% glycerol after which a coverslip was mounted over the grid. Coverslips were 
fixed using Scotch Pressure Sensitive Tape. Samples were imaged with a Leica TCS 
SP8 confocal microscope (63x oil lens, N.A.=1.4). Confocal microscopy was used as 
it allowed to make image stacks from the sections at different focus planes; this 
was convenient as the sections were found to be in different focus planes whilst 
placed between the glass slides and coverslip. After fluorescence microscopy the 
EM grid with the sections was remove from the glass slide, rinsed in distilled 





Excess of uranylacetate/methylcellulose was blotted away and grids were air-
dried. EM imaging was performed with a Tecnai 12 Biotwin transmission electron 
microscope (FEI) at 120 kV acceleration voltage.  
 
Correlation of confocal and EM images was performed in Photoshop CS6. In 
Adobe Photoshop, the LM image was copied as a layer into the EM image and 
made 50% transparent. Transformation of the LM image was necessary to match 
it to the larger scale of the EM image. This was performed via isotropic scaling and 
rotation. Interpolation settings; bicubic smoother. Alignment at high 
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Correlative Light and Electron Microscopy reveals Discrepancy 










Fluorescence Microscopy (FM) is a powerful imaging tool that can be employed to 
track, localise and monitor biomolecules within cellular systems. However, with 
fluorescence measurements only the position of the labelled biomolecules can be 
studied in relation to other fluorescently-labelled biomolecules, but the 
morphology of subcellular structures wherein they reside remains invisible. 
Conversely, Electron Microscopy (EM) enables observations at nanometer-scale 
resolution and is therefore often employed to gain ultrastructural characterisation 
of the subcellular environment pertinent to the biomolecules initially investigated 
with FM.1-5   
 
The location of biomolecules within EM imaged specimen can be visualised upon 
gold labelling. Colloidal gold is electron dense and, due to its punctate and precise 
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labelling pattern, it is favourable for the localisation of biomolecules within 
structures studied at nanometer scale.6, 7 Gold labelling can be broadly applied, 
e.g. in combination with immunocytochemistry (through direct antibody coupling 
or in combination with protein A), but also with lectins and other binding 
proteins.6, 8 This allows recognition of fluorescent reporter proteins (such as green 
fluorescent protein (GFP)), fluorophores, or direct epitopes studied with FM.9 The 
preferred method for preparing biological material for gold labelling is the 
Tokuyasu cyosectioning technique. This technique is the only post-embedding on-
section immunolabelling approach that does not require dehydration by polar 
solvents before application of affinity markers. It is therefore that thawed 
crysosections tend to give the highest accessibility of antibodies to the antigens 
and are the best for most purposes on-section labelling strategies.10-12 
 
Besides colloidal gold markers, directly visible in the electron microscope, one can 
also use Correlative Light and Electron Microscopy (CLEM) to directly visualise 
fluorescent markers on EM imaged specimen. With CLEM, specific biomolecules 
and cellular structures can be identified at low magnification with FM, followed by 
ultrastructural assessment of subcellular location and context with EM.13, 14 CLEM 
enables the detection of rare cellular events and allows interpretation of 
fluorescent labelling on low magnification/large overview images in contrast to 
colloidal gold markers, which are too small to detect at low magnification. A 
downside of fluorescence-based CLEM is that correlation of images requires 
enlargement of the FM image to cover the high magnification EM image. This 
enlargement results in diffuse fluorescent signals with a diameter of a few 
hundred nanometers that cannot be related to the exact location of proteins of 
interest, which can be around 4 nm in diameter and may be associated with 
organelles as small as 30 nm.15  
 
It was envisaged that the center of the fluorescent signals could be found by 
combining gold labelling and fluorescence-based CLEM in a single experiment. 
Surprisingly, this combination showed for the lysosomal membrane protein 
LAMP-1 a discrepancy between the distribution of gold and fluorescent label. To 
understand the scope and implications of this phenomenon, a series of 
experiments were devised involving bioorthogonal labelling of cryosections.16 
Bioorthogonal labelling is a chemical labelling strategy whereby firstly a small, 
physiologically inert chemical group is incorporated into a biomolecule of interest, 
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which is subsequently reacted with a detection group using a highly selective 
chemical reaction. With this approach a wide range of biomolecules can be 
labelled, with high specificity and minimal perturbations.17, 18 Through the use of 
bioorthogonal labelling it was possible to compare fluorescence and immunogold 
labelling of model membrane-associated or soluble epitopes using the same 
labelling procedures. It was discovered that in particular membrane-associated 
antigens are strongly labelled with gold particles, whereas the signal of 
fluorescence labelling of the same target molecules  is weak or not detectable. 
 
Results 
Defining the problem 
In order to determine the position of fluorophore-tagged antigens within cellular 
ultrastructures, a previously described CLEM strategy was applied for detection 
and localisation of fluorescent tags16 and labelled fluorophore-antigen complexes 
with immuno gold particles. This strategy involves cryosectioning according to the 
Tokuyasu technique and thus allows fluorescence-based CLEM and immunogold 
labelling on the same specimen sections. Labelling strategies employed in this 
study are schematically displayed in all figures and the corresponding symbol 
legends are shown in Table 1. The fluorescence-gold labelling strategies employed 
in this study all rely on indirect fluorophore to gold conjugation upon use of 
antibodies. This indirect  fluorophore to gold conjugation has been shown to 
minimise the possible quenching of the fluorescence signals and is therefore the 


















Table 1. Symbols legends labelling strategies. 
  component symbol 
 
 
Protein A conjugated gold 
 
 




















It was chosen to apply this strategy to the lysosomal membrane glycoprotein 
LAMP-1, a major protein component of the lysosomal membrane.20 LAMP-1 is 
widely used as a marker for the identification of late endosomes and lysosomes 
with FM and EM.21, 22 Bone Marrow derived Dendritic Cells (BM-DCs) were 
cultured, processed for cryosectioning23 and sectioned into 75 nm thick sections, 
followed by primary labelling with a fluorescent (AlexaFluor 647) rat anti mouse 
LAMP-1 antibody and secondary labelling with 15 nm protein A-coated gold 
particles after a rabbit anti-rat IgG binding step (Figure 1A, Strategy). Sections 
were then imaged with a confocal microscope, after which sections were stained 
with uranylacetate and imaged using an electron microscope. The FM and EM 
images were superimposed (Figure 1A, CLEM), and the corresponding label 
distributions were analysed (Figure 1A, Label distribution). To facilitate 
interpretation of the gold labelling in relation to the fluorescent signals, all gold 
particles are highlighted with green dots. Upon the morphological appearance of 
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a visible membrane profile several organelles are depicted white when 
fluorescent label is associated and yellow when gold label is associated. It was 
found that the distribution of LAMP-1 gold only partially overlapped with the 
distribution of LAMP-1 fluorescence, while LAMP-1 fluorescence was always 
associated with gold label (Figure 1A, Label distribution). Note that gold can be 
localised on fluorescent labels, but not on organelle structures. Moreover, areas 
with high fluorescence were not highly gold-labelled. Quantification of overlap 
revealed that only 66% of the gold particles colocalised with fluorescence.  
 
The above results were deemed remarkable, considering that the gold label was 
directed towards the fluorescent LAMP-1 antibody. To explore whether such label 
discrepancy represents a general phenomenon associated with combining 
fluorescence and gold techniques, the CLEM and immunogold approach was 
tested for non membrane-bound molecules, namely cathepsins papain-like 
cysteine proteases known to reside within lysosomes. In order to label cathepsins 
with fluorescence and immunogold, BM-DCs were incubated with a DCG-04 
probe, which binds to active cathepsins and contains a bioorthogonal azide-
group.24, 25 After cryo sectioning of BM-DCs, the DCG-04-azide was labelled with 
an AlexaFluor 488 fluorophore using an on-section copper-catalysed Huisgen 
cycloaddition (ccHc) reaction.16 This was followed by an immunogold labelling 
step directed against the AlexaFluor 488 (Figure 1B, Strategy). The distribution of 
cathepsin gold label corresponded well with the distribution of the cathepsin 
fluorescence label (Figure 1B, Label distribution). Quantification showed that 87% 
of the gold particles co-localised with the fluorescence signal. These results 
suggest that the degree of correspondence between gold and fluorescence label 



















Figure 1. Labelling of LAMP-1 with gold results in different label patterns compared to the labelling 
of LAMP-1 with fluorescence. (A) BM-DC sections were labelled with a fluorescent AlexaFluor647 
(red) rat anti-mouse LAMP-1 antibody, and with protein A-coated gold particles. Gold particle 
labelling was performed using a rabbit anti-rat binding step (Strategy). Representative CLEM image 
(CLEM). Upon the morphological appearance of a visible membrane profile several organelles are 
depicted white when fluorescent label is associated and yellow when gold label is associated (Label 
distribution). (B) BM-DCs were incubated with DCG-04-azide and were labelled with AlexaFluor488 
alkyne (green) and with protein A coated gold directed against AlexaFluor488 using a rabbit anti-
AlexaFluor448 binding step (Strategy). Representative CLEM image (CLEM). Upon the morphological 
appearance of a visible membrane profile, several organelles are depicted white when fluorescent 
label is associated, and yellow when gold label is associated (Label distribution). Scale bars 500 nm. 
 
Analyzing the problem 
In contrast to LAMP-1, the distribution of gold label corresponded well with the 
distribution of the fluorophore label for cathepsins. Since LAMP-1 and cathepsins 
are associated with the same organelles, it was anticipated to see predominantly 
overlap of the LAMP-1 and cathepsin label distributions.26 To test this, LAMP-1-
associated organelles were defined as being positive for cathepsin label and 
distributions of LAMP-1 gold (Figure 2A, Strategy) and LAMP-1 fluorescence 
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(Figure 2B, Strategy) in relation to these cathepsin-positive organelles were 
analysed. As expected, association of LAMP-1 with cathepsin-positive organelles 
was confirmed with immunogold labelling (Figure 2A, CLEM and Label 
distribution). However, immunofluorescence labelling of LAMP-1 showed that 
LAMP-1 also associated with cathepsin-negative organelles and that cathepsin 
positive vesicles are not always associated with LAMP-1 (Figure 2B). To exclude 
the possibility that the secondary antibody in the gold label strategy represented 
in Figure 2A would influence the labelling, the protein A gold was substituted for 
protein A AlexaFluor 647 (Figure 2C, Strategy) and the result of this strategy 
(Figure 2C, label distribution) was compared with the results shown in Figure 2B. 
Statistical colocalisation analysis (Figure 2C, colocalisation) showed that 
substitution of protein A gold by protein A AlexaFluor 647 resulted in a label 
distribution similar to the distribution shown in Figure 2B. Collectively, these 
results indicate that the application of gold particles within a label strategy 
influences the immunodetection of antigens on sections.  
 
Testing the hypothesis 
The results presented so far show that the distribution of immunogold label for 
LAMP-1 does not completely correlate with immunofluorescent labelling of the 
same antigen. As this was prominently observed for the LAMP-1 epitope, but not 
for the cathepsin epitope, it was postulated that there could be an effect of the 
immediate surrounding of the epitope on the ability of the gold conjugates to 
bind to cognate epitopes. Since LAMP-1 is a membrane-bound molecule while 
cathepsin is soluble, it was hypothesised that immunogold labels membrane-
bound molecules differently from soluble epitopes. It was thus set out to install 
the same bioorthogonal group used to label cathepsins via the DCG-04 probe on a 
membrane-associated epitope, creating the same covalent fluorophore 
introduction in a membrane associated context. This was achieved by installing 
the bioorthogonal group on sialylated glycans,27 as these constitute parts of 
membrane-bound molecules.  
 
Jurkat cells were incubated with Ac4-N-azidoacetylmannosamine (Ac4-ManNAz), 
to add a bioorthogonal functionality to sialylated glycans under conditions 
reported previously.16 Cryo sections from these cells were subjected to the same 
labelling strategy as used for the cathepsins above. To eliminate the possibility 





influence either the binding of AlexaFluor 488 alkyne or recognition of AlexaFluor 
488 by anti AlexaFluor 488 IgG, modified epitopes were first doublelabelled with 
AlexaFluor alkyne and protein A AlexaFluor (Figure 3A and B, Strategy). Similar 
overlap of the two fluorophores was observed for both epitopes (Figure 3A and B, 
Label distribution) with no significant difference between the two azide-modified 
epitopes (Figure 3B, Colocalisation), meaning that the affinities of the two labels 
were not altered upon the epitope or cell type change. Next, the sialylated glycans 
were doublelabelled and protein A AlexaFluor was substituted for protein A gold 
(Figure 3C, Strategy). It was found that the gold label localised primarily on the 
plasma membrane, whereas the fluorescent signal predominantly labelled 
intracellular structures (Figure 3C, CLEM). Quantification of colocalisation (Figure 
3C, Label distribution) revealed that again only 64% of the gold label co-localised 
with the fluorescent foci, lending credence to the hypothesis that the cellular 
location of an epitope influences the degree of gold labelling. For soluble epitopes 
the degree of gold label is relatively low compared to the fluorescent signal, 
whereas the membrane-bound epitopes get highly labelled with gold, even when 
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Figure 2. Labelling with gold particles shows a different antigen distribution than with fluorescent 
labelling. (A) BM-DCs were incubated with DCG-04-azide and labelled with AlexaFluor488 alkyne 
(green). Sections were subsequently labelled with anti-LAMP-1 and protein A-coated gold directed 
against the LAMP-1 antibody using a rabbit anti-rat binding step (Strategy). CLEM images obtained 
(CLEM) were analysed for label distribution and gold distribution is marked with red dots. Structures 
that are positive for LAMP-1 gold are depicted in white and structures positive for cathepsin 
fluorescence are depicted in yellow. (B) BM-DCs were incubated with DCG-04-azide and were 
labelled on section with AlexaFluor488 alkyne (green). Sections were subsequently labelled with 
fluorescent AlexaFluor647 anti-LAMP-1 (red) (Strategy). CLEM images obtained (CLEM) were 
analysed for label distribution. Structures positive for LAMP-1 fluorescence are depicted in white 
and structures positive for cathepsin fluorescence in yellow. (C) BM-DCs were incubated with DCG-
04-azide and were labelled on section with TAMRA alkyne (green). Sections were subsequently 
labelled with anti-LAMP-1 and protein A AlexaFluor488 fluorophore (red) directed against the LAMP-
1 antibody using a rabbit anti-rat binding step (Strategy). A representative confocal image of this 
sample is shown in Fluorescence. Colocalisation analysis of the labelling sequences in (B) and (C) 






Figure 3. The cellular location of an epitope influences gold labelling, resulting in a discrepancy 
between fluorescence and gold label distribution. (A) Jurkat cells were incubated with N-
azidoacetylmannosamine and were labelled on section with AlexaFluor488 alkyne (green). Sections 
were subsequently labelled with a AlexaFluor647 protein A fluorophore directed against the 
AlexaFluor488 using a rabbit anti-rat binding step (Strategy). (B) BM-DCs incubated with DCG-04-
azide were labelled on section with AlexaFluor488 alkyne (green) and protein A AlexaFluor647 (red) 
directed toward AlexaFluor488 using a rabbit anti-AlexaFluor488 binding step. Colocalisation 
analysis of sialylated glycans and protein A compared to cathepsins and protein A (Colocalisation). (C) 
Jurkat cells were incubated with N-azidoacetylmannosamine and were labelled on section with 
AlexaFluor488 alkyne (green). Gold particle labelling was performed using a rabbit anti-
AlexaFluor448 binding step (Strategy). Representative CLEM image (CLEM). Organelles positive for 
sialylated glycan-fluorescence are depicted in yellow and organelles positive for sialylated glycan-
gold are depicted in white. The distribution of these spheres is displayed in the context of the label 
distribution (Label distribution). Scale bar 500 nm. 
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Conclusion 
In order to translate information of FM studies to EM analysis, biomolecules 
initially observed with the former need to be labelled in a manner compatible 
with EM. Traditionally this is performed using immunogold labelling of 
fluorescently detected biomolecules. Here the discrepancies arising between 
distributions of fluorescence and gold labelling were identified and explored. It 
was found that a subset of cathepsin-positive organelles is negative for LAMP-1 
when labelling is done by fluorescence, but positive for LAMP-1 when labelling is 
done with gold particles. Variations in label distributions can be explained by 
marker heterogeneity in phagosomal, endosomal and lysosomal structures.28-30 
However, such heterogeneity cannot explain that the label distribution pattern 
changes upon changing the type of label (gold vs fluorescent label). It was 
reasoned that the antigen detection level could change upon changing the type of 
label, but that the label distribution pattern should not.  
 
In a comparison of fluorescent and gold label it can be argued that the localisation 
of diffuse enlarged fluorescent signals may result in a less distinct mapping of 
positive structures, and that fluorescence can be difficult to detect when label 
density is weak, which is especially the case for fluorescence labelling on non-
dense structures such as membranes. However, since the fluorescence intensity is 
related to the concentration of the epitope, there should still be an overlap of 
fluorescence and gold label,31 and this is not expressed by the observed 
discrepancy. 
 
On top of this gold labelling may show different antigen detection levels. 
Variations in labelling of conjugated gold particles have been previously reported 
by Griffiths and Hoppeler, describing variations in immunogold labelling 
efficiencies for the ER, Golgi apparatus and viral membranes.32 In their study the 
ER membranes were found to exhibit the highest labelling efficiency compared to 
the Golgi apparatus or viral membranes. These observations are supported by 
others noting profound variations in immunogold labelling efficiency between 
different cellular compartments and structures.33-35 It is generally considered that 
cross-linking of target molecules by fixatives, as well as steric hindrance and 
valency of both target and ligand molecules constitute factors that influence 
labelling efficiency.36 Other investigators report that the density of cellular 





is almost only surface labelling whereas the less dense endoplasmic reticulum 
gets more prominently labelled.37 It was postulated that these epitope availability 
effects more strongly affect gold labelling compared to fluorescence labelling, 
resulting in the discrepancies observed between these labelling strategies.  
 
If epitopes of interest are found in various structures within the same specimen, 
gold labelling may result in a biased detection of target molecules.  As a 
consequence it may be argued that in this context fluorescence labelling is 
preferable to gold labelling. However, to reach the punctuality of the gold 
particles, the detection of these fluorescence labels needs to be at a higher 
resolution. Super-resolution microscopy techniques, such as STORM and PALM, 
may serve this purpose as these techniques allow to precisely localise molecules 
at a resolution of a few nanometers. Moreover, examples of their applications to 
CLEM have yet been explored.15, 38 Another approach resulting in high resolution 
labelling includes labels capable of polymerizing diaminobenzidine (DAB) . It has 
been shown that photooxidation-based polymerisation of DAB occurs within a 
few nanometers away of the epitope.39-42 Application of these high resolution 
methods could pave the way to provide alternative labels for accurate mapping in 























BM-DCs and Jurkat cells were cultured as described elsewhere16. BM-DCs were 
incubated for 2 hours with DCG-04-azide 43 (final concentration of 10 μM), after 
which the cells were washed with PBS and kept for 2 h in fresh medium. Jurkat 
cells were incubated for 3 days with 50 μM of N-azidoacetylmannosamine 
(MannAz, Invitrogen) from stock solutions in DMSO.  
 
Samples were prepared for cryosectioning as described elsewhere 16, 44. Briefly, 
BM-DCs and Jurkat cells were fixed for 24 h in freshly prepared 2% PFA in 0.1 M 
phosphate buffer. Fixed cells were embedded in 12% gelatin (type A, bloom 300, 
Sigma) and cut with a razor blade into 0.5 mm3 cubes. The sample blocks were 
infiltrated in phosphate buffer containing 2.3 M sucrose for 3 h. Sucrose-
infiltrated sample blocks were mounted on aluminum pins and plunged in liquid 
nitrogen. The frozen samples were stored in liquid nitrogen. 
 
Ultrathin cell sections of 75 nm were obtained essentially as described 
elsewhere16. Briefly, the frozen sample was mounted in a cryo-ultramicrotome 
(Leica). The sample was trimmed to yield a squared block with a front face of 
about 300 x 250 μm (Diatome trimming tool). Using a diamond knife (Diatome) 
and antistatic device (Leica) a ribbon of 75 nm thick sections was produced that 
was retrieved from the cryochamber with the lift-up hinge method45. A droplet of 
1.15 M sucrose was used for section retrieval.  
 
Obtained sections were transferred to a specimen grid previously coated with 
formvar and carbon grids were additionally coated with 100 nm FluoroSpheres 
carboxylate-modified (350/440) (Life Technologies).  
 
On-section labelling 
Sections that were click-labelled with AlexaFluor488/TAMRA alkyne and 
immunogold-labelled were labelled as follows; thawed cryosections on an EM grid 
were left for 30 minutes on the surface of 2% gelatin in phosphate buffer at 37°C. 
Subsequently grids were incubated on drops of PBS/glycine and PBS/glycine 
containing 1% BSA. Grids were then incubated on top of the ccHc- cocktail (0.1 M 





mM amino-guanidine, 5 μM AlexaFluor488/TAMRA alkyne (Invitrogen) for 1 h and 
washed 6 times with PBS. Sections were then blocked again with PBS/Glycine 
containing 1% BSA after which the grids were incubated for 1 h with 0.1 M 
PBS/glycine 1% BSA (blocking solution) supplemented with a rabbit IgG anti Alexa 
488 antibody (Invitrogen). After washing with PBS/Glycine and blocking with 
PBS/glycine 0.1% BSA, grids were incubated for 20  minutes on PBS/glycine 1% 
BSA supplemented with protein A coated 10 or 15 nm goldparticles (CMC, Utrecht 
University). Grids were then washed with PBS, labelled with DAPI and additionally 
washed with PBS and aquadest. In case of protein A AlexaFluor labelling, protein 
A-coated goldparticles were replaced with protein A Alexa 488 or protein A Alexa 
647 (20 µg/ml). 
 
In case of immunofluorescence and immunogold labelling against LAMP-1 thawed 
cryosections on an EM grid were left for 30 minutes on the surface of 2% gelatin 
in phosphate buffer at 37°C. Grids were washed 5 times with PBS/glycine and 
blocked with PBS/glycine containing 1% BSA after which the grids were incubated 
for 1 h with PBS/glycine 1% BSA supplemented with a rat anti-mouse LAMP-1 
AlexaFluor647 (Biolegend, Cat. 121609). Grids were then washed 5 times with 
PBS/glycine and blocked again with PBS/glycine containing 1% BSA after which the 
grids were incubated for 1 h with PBS/glycine 1% BSA supplemented with a rabbit 
IgG anti-rat (Nordic Immunology). After washing with PBS/glycine and blocking 
with PBS/glycine 0.1% BSA, grids were incubated for 20  minutes with PBS/glycine 
1% BSA supplemented with protein A coated 10/15 nm goldparticles (CMC, 
Utrecht University). Grids were then washed with PBS, labelled with DAPI and 
additionally washed with PBS and aquadest. In case of protein A Alexa labelling, 
protein A-coated 10/15 nm goldparticles were replaced for protein A Alexa 488 or 
protein A Alexa 647 (20 µg/ml).  
 
In case click labelling and LAMP-1 labelling were performed on the same section, 
click labelling was preformed prior to the LAMP-1 labelling steps. 
 
Microscopy and correlation 
The CLEM approach used was adapted from Vicidomini et al. and has been 
described elsewhere16. Briefly, grids containing the sample sections were washed 
with 50% glycerol and placed on glass slides (precleaned with 100% ethanol). 
Grids were then covered with a small drop of 50% glycerol, after which a coverslip 
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was mounted over the grid. Coverslips were fixed using Scotch Pressure-Sensitive 
Tape. Samples were imaged with a Leica TCS SP8 confocal microscope (63x oil 
lens, N.A.=1.4). After confocal microscopy the EM grid with the sections was 
removed from the glass slide, rinsed in distilled water and incubated for 5  
minutes on droplets of an aqueous solution containing 2% methylcellulose and 6% 
uranyl acetate. Excess of methylcellulose/uranyl solution was blotted away and 
grids were air-dried. EM imaging was performed with a Tecnai 20 transmission 
electron microscope (FEI) operated at 120 kV acceleration voltage.  
 
Correlation of confocal and EM images was performed in Adobe Photoshop CS6. 
In Adobe Photoshop, the FM image was copied as a layer into the EM image and 
made 50% transparent. Transformation of the FM image was necessary to match 
it to the larger scale of the EM image. This was performed via isotropic scaling and 
rotation using interpolation settings; bicubic smoother. Alignment at low 
magnification was carried out with the aid of nuclear DAPI staining in combination 
with the shape of the fluorescently labelled cells. At high magnification alignment 
was performed using the fiducial beads 46.  
 
Colocalisation analysis and quantification of label distributions 
Upon the morphological appearance of a visible membrane profile organelles 
were depicted either positive for gold or for fluorescence. For the determination 
of structures positive for gold only structures positive for two or more particles 
were depicted. 
 
Colocalisation of gold and fluorescence was calculated as a percentage by 
quantification of the overlap of gold and fluorescence using the count tool in 
Photoshop. With this strategy gold particles were counted that either colocalised 
with fluorescence or did not colocalise with fluorescence.  
 
The Pearson coefficient was determined on magnified confocal images of protein 
A double labelled samples using the Coloc2 function in ImageJ after background 
was corrected to eliminate nonspecificity. These images were obtained in Adobe 
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Detection of Bioorthogonal Groups by Correlative Light and Electron 










Phagocytic degradation is a question of great biological relevance, as it is one of 
the key mechanisms by which the immune system keeps pathogens at bay. As a 
consequence, subversion of the phagolysosomal pathway is a survival strategy 
employed by a wide range of parasites, which collectively are responsible for a 
great amount of human morbidity and mortality.1  
 
The interaction between immune cells and pathogenic bacteria is very difficult to 
study2, as intracellular pathogens can be non-trivial to grow ex vivo3 and very 
difficult to genetically alter. Even in (rare) cases where these bacteria can be 
genetically modified,4 imaging their encounters with host phagocytes is limited to 
encounters where successful infection is established. Encounters whereby the 
pathogens are killed and degraded are difficult to image, as the proteolysis that is 
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a hallmark of successful phagocytic maturation5 results in the degradation of 
reporter proteins and epitopes.6  
 
Bioorthogonal chemistry is a powerful tool for labelling of (sub)-populations of 
biomolecules in complex biological systems7 and could be employed to 
circumvent these problems. The approach relies on the introduction of a small, 
physiologically inert chemical group into a biomolecule of interest that can 
subsequently be visualised using a selective reaction.8 The small size, biological 
stability of the chemical group, and the wide range of biomolecules that can be 
labelled with this approach makes this method a valuable part of the biochemist's 
toolkit.9, 10  
 
Bolstered by the recent successful imaging of a pathogen inside a host phagocyte 
through the use of a bioorthogonally-modified cell wall component, D-alanine,11-13 
it was envisaged that bioorthogonal bacteria could also be used to image 
degradation events in host phagocytes. Bioorthogonal non-canonical amino acid 
tagging (BONCAT)14, 15 for pan-proteomic incorporation of bioorthogonal groups16, 
17 would allow the labelling of a wide range of bacterial species without the need 
for genetic modification.18 Furthermore, unlike reporter proteins, bioorthogonal 
groups, such as azides,19, 20 have been shown to be stable in the harsh chemical 
environments of the phagolysosomal system and should therefore be detectable 
even when extensive proteolysis has occurred.  
 
Information about subcellular localisation is of key importance when studying 
parasite–phagocyte-interactions as movement between organelles may be 
essential to the life cycle of certain parasites.1, 21 Only transmission electron 
microscopy (TEM)-based techniques allows the study of these pathogens in their 
subcellular context, as it provides substructural information on the position of any 
label/antigen within the cell.22 However, in contrast to superresolution imaging,23, 
24 no methods have been reported that allow the visualisation of bacterial 
degradation using bioorthogonal labelling in combination with EM imaging.25 
 
This chapter describes the application of a correlative light electron microscopy 
(CLEM)-based imaging approach for the visualisation of bioorthogonal groups, 
which allows the imaging of BONCAT-labelled bacteria inside phagocytes (Figure 
1); even as they are being degraded. This approach combines the benefits of 
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confocal microscopy – which allows widefield navigation to areas of interest26 – 
with those of EM – which provides narrow-field high-resolution information about 
the interior of the cell.22 All approaches described here on the model organism 
Escherichia coli (E. coli) are amenable to application to pathogens, which would 
open new avenues for studying the events leading to bacterial clearance and/or 
establishment of intracellular residence by intracellular pathogens. 
 
Figure 1: Overview: (A) phagocytosed azido-E. coli  can be fluorescently visualised in an ultrathin 
cryosection using a copper-catalysed Huisgen cycloaddition reaction with a fluorophore; (B) overlay 
of this image on an electron micrograph provides an ultrastructural context for the signal with 
nanometer-scale resolution. As the bioorthogonal handle is stable to proteolysis, degraded bacteria 
can be visualised in this manner. 
 
Results 
Comparison of GFP-E. coli  and azido-E. coli for imaging phagolysosomal 
degradation  
Most CLEM studies employ the fusion of fluorescent proteins to a protein of 
interest or antibody-based approaches to allow their identification and 
localisation.22 These labelling approaches have shown to be of great value for the 
imaging of specific proteins in their cellular context, but only in the cases where 
genetic modification of the organism is possible and where the attachment of the 
fluorescent proteins does not affect protein function.27 Immunofluorescence has 
also been used, but combined with CLEM it either compromises ultrastructure (by 
virtue of the need of fixation and permeabilisation prior to CLEM-sample 
preparation)28, or suffers from a notoriously low success rate due to compromised 








To determine whether the BONCAT-based labelling approach has advantages over 
genetic methods for the detection of phagocytosed bacteria during degradation,  
the fate of azido-E. coli  was compared to that of GFP-expressing E. coli  (Figure 2). 
Mouse bone marrow-derived dendritic cells (BM-DCs)30, 31 were incubated with 
azido-E. coli  or GFP-E. coli  for 45 minutes. After washing, the cells were chased 
for 1 h, 2 h or 3 h prior to fixation, bioorthogonal modification of the azides 
(where present), and confocal imaging (Figure 2) – time points in which 
maturation of a phagosome to a phagolysosome is known to take place in these 
cells.32 
 
To assess whether the fluorescent signal originated from intact or (partially) 
degraded bacteria, extranuclear DAPI staining was analysed: colocalisation of the 
fluorescent signal with the extra-nuclear DAPI indicates the intactness of the 
bacterial DNA, which in turn indicates the intactness of the bacterium.33 Absence 
of this colocalisation (i.e. 488 nm single-positive foci) indicated the degradation of 
the bacterial genome and thus death. The azide-based signal persisted 
significantly more than the GFP-signal after killing of the bacterium; as indicated 
by the significantly larger number of DAPI-negative/azide-positive foci at all time 
points of the chase period compared to DAPI-negative/GFP-positive foci (Figure 3). 
Many of the azide-positive foci were smaller than intact DAPI/azide double 
positive foci, indicating these signals to originate from partially degraded bacteria.  
 
CLEM imaging of azido-E. coli  after uptake by BM-DCs.  
We obtained ultrastructural information about the location of these smaller, 
DAPI-negative foci by performing CLEM analysis on azido-E. coli-treated BM-DCs 
samples at all four time points (Figure 4 and Figure 5). Co-staining with the 
lysosomal marker Lysosomal Associated Membrane Protein-1 (LAMP-1) revealed 
that these degraded fragments only partially resided in LAMP-1-positive late 
endosomes/lysosomes. This ties in with previous studies showing the existence of 
a second population of phagosomes in DCs, which do not acidify and never 
become LAMP-1 positive.34 This set of phagosomes has been implicated in DC-
specific functions, such as cross-presentation.35, 36 Morphological information 
obtained from TEM showed that the azide-positive/DAPI-positive foci were intact 
bacteria, whereas the DAPI-negative foci showed no identifiable bacterial 
morphology, indicating that this technique allows the imaging of partially 
degraded bacteria inside mammalian phagocytes (Figure 4 and Figure 5) . 
- 78 -
Detection of Bioorthogonal Groups by CLEM  allows Imaging of Degraded Bacteria in Phagocytes 
 
 
Figure 2: Confocal microscopy of (A) azido-E. coli  or (B) GFP-E. coli  after phagocytosis. BM-DCs were 
pulsed with either azido-E. coli  or GFP-E. coli  (45 minutes pulse). Cells were fixed after a 2 h chase 
and stained with DAPI (blue), anti-actin (red) and, in case of azido-E. coli , AlexaFluor-488 alkyne 
(green = either GFP or AlexaFluor-488). (i) DAPI/488 nm overlay; (ii) DAPI only; (iii) all fluorescent 
channels overlay. Yellow arrows indicate a 488-single positive focus, white arrows a DAPI/488 nm 
double positive focus. 
Figure 3: Comparison of GFP-E. coli and azido-E. coli for imaging phagolysosomal degradation in BM-
DCs. BM-DCs were incubated with either GFP-E. coli  or azido-E.coli cells for 45 minutes. Cells were 
washed with PBS to remove unbound/non-internalised E. coli. After a 45 minutes pulse, 1 h chase, 
2 h chase or 3 h chase cells were fixed with 4% PFA for 15 minutes. Azido-E. coli containing cells 
were labelled with AlexaFluor-488 alkyne using copper-catalysed Huisgen cycloaddition-conditions. 
From each condition confocal microscopy pictures were made. Based on these pictures the average 
number of green foci, that represented degraded bacteria per cell, was determined. Only the foci 
that were within the focus plane of the cell (determined by the actin staining) were counted and had 

















Figure 4: CLEM imaging of phagocytosed azido-E. coli: BM-DCs were pulsed with azido-E. coli  (45 
minutes pulse). Cells were washed with PBS to remove unbound/non-internalised E. coli. Samples 
were fixed immediately after pulsing (A–D) or after a 3 h chase (E–H). Cells were subjected to 
Tokuyasu sample preparation and cryosectioned into 150 nm sections. Sections were reacted with 
AlexaFluor-488 alkyne using ccHc-conditions (green), anti-LAMP-1 (red) and DAPI (blue). DAPI 
staining and blue fiducials (indicated with circles in B and F) were used for correlation purposes. 
(A/E) Confocal microscopy images; (B/F) CLEM image obtained from overlay LM and EM pictures; (C, 
D, G and H) CLEM details from (B/F), showing LAMP-1 and 488 nm channels (C/G) or 488 nm alone 
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Figure 5: CLEM imaging of mouse BM-DCs infected with azido-E. coli. BM-DCs were incubated with 
E. coli  cells for 45 minutes. Cells were washed with PBS to remove unbound/non-internalised E. coli. 
After a 45 minutes pulse (A.i-v), 1 h chase (B.i-v), 2 h chase (C.i-v) or 3 h chase (D.i-v) cells were fixed 
in 2% PFA, subjected to Tokuyasu sample preparation (including gelatin embedding and sucrose 
infiltration) and crysectioned into 150 nm sections. Sections were reacted with AlexaFluor-488 
(green) alkyne using copper-catalysed Huisgen cycloaddition reaction, anti-LAMP-1 (red) and DAPI 
(blue). DAPI staining and blue fiducials were used for correlation purposes. (A.i-D.i) Confocal 
microscopy image of bioorthogonally tagged E. coli B834 incubated with mouse BM-DCs (A.i) 45 
A.i B.i C.i D.i 
A.ii B.ii C.ii D.ii 
A.iii B.iii C.iii D.iii 
A.iv B.iv C.iv D.iv 





minutes pulse (B.i) 1 h chase (C.i) 2 h chase (D.i) 3 h chase. Green = AlexaFluor-488, Red = LAMP-1, 
Blue = nuclear DAPI stain and fiducial beads. (ii) Detail from i. (iii) CLEM image obtained from overlay 
EM picture and figure ii, using blue fiducials and DAPI stain for correlation. (iv) Similar detail from 




By combining BONCAT with CLEM-imaging, we have established a new approach 
that allowed us to visualise bioorthogonally modified bacteria in an ultrastructural 
cellular context, even during late stages of bacterial degradation. With this 
approach degradation events in a cell can be identified at low magnification with 
confocal microscopy using bioorthogonal labelling, after which ultrastructural 
information about their subcellular location and context can be obtained with EM. 
This is of great interest for the study of obligate intracellular parasites that are 
very hard to study by any other means.  
 
As the application of bioorthogonal chemistry is ever expanding, the CLEM-
imaging method of bioorthogonal groups described here could also be of great 
benefit to the study of labelled biomolecules in other fields in which 
bioorthogonal imaging has proven its value.25 Application of this approach to 
other bioorthogonal assays (for instance, lipid imaging37 and the imaging of newly 
synthesised proteins38), and perhaps in combination with some of the more 
recently developed bioorthogonal chemistries39 will allow the provision of 
additional structural information to the current imaging methods available for 














E. coli   culturing conditions and growth measurements  
E. coli B834(DE3) bacteria were grown overnight at 37°C in Lysogeny Broth (LB) 
medium. The following day cultures were diluted 1:50 in LB medium and grown at 
37°C till an OD600 between 0.3-0.5. Subsequently cells were collected and 
resuspended in Selenomet medium (Molecular Dimensions) and supplemented 
with either 4 mM Azidohomoalanine (Aha) (Bachem) or 4 mM Methionine (Met) 
(Sigma-Aldrich). After 1 h OD600 were measured and cells were collected by 
centrifugation for BM-DC infection experiments.  
 
E. coli B834(DE3) GFPA206K was grown overnight at 37°C in LB medium. The 
following day cultures were diluted 1:50 in LB medium and grown at 37 °C till an 
OD600 between 0.3-0.5. Throughout culturing, cultures were supplemented with 
100 µg/ml Ampicillin. The vector pRD35 for the constitutive expression of GFPA206K, 
was constructed by cloning GFP into pUC21 using NsiI and MluI restriction sites. 
An A206K mutation was introduced by site-directed mutagenesis PCR to prohibit 
dimerisation of GFP.40 The constitutive hns promoter and ribosomal binding site 
(the 258 bases upstream of the E. coli hns gene), were amplified by PCR, using 
E. coli K12 as a template, and positioned upstream of GFP by way of XhoI and NsiI. 
Used primers are indicated in Table 1.   
 
GFP fw NsiI ACA-ATG-CAT-AGT-AAA-GGA-GAA-GAA-CTT-TTC-ACT-GGA-GTT-G 
A206K fw CCT-GTC-CAC-ACA-ATC-TAA-ACT-TTC-GAA-AGA-TCC-C 















Mammalian cell culture conditions 
Mouse bone marrow derived dendritic cells (BM-DCs) were generated from 
B57BL/6 mice bone marrow essentially as described30
 
with some modifications. 
Briefly, bone marrow was flushed from femurs and tibia and cells were cultured 
in IMDM (Sigma Aldrich) supplemented with 8% heat-inactivated fetal calf serum, 
2 mM L-glutamine, 20 μM 2-Mercaptoethanol (Life Technologies), penicillin 100 
l.U./mL and streptomycin 50 μg/mL in the presence of 20 ng/mL GM-CSF 
(ImmunoTools). Medium was replaced on day 3 and 7 of culture and the cells 
were used between days 10 and 13.  
 
E. coli B834(DE3) cells were added to the BM-DCs as suspensions in PBS in a ratio 
of approximately 25:1, respectively. After 45 minutes of incubation unbound/non-
internalised E. coli cells were washed off (2x PBS) and medium was replaced. At 
the indicated time points cells were subjected to confocal microscopy or Tokuyasu 
sample preparation.  
 
Whole cell confocal microscopy 
BM-DCs were seeded (7 x 104) on a 12-well removable chamber slide (Ibidi) and 
left to grow O/N. The following day E. coli  B834 cells harboring either 
GFP/Aha/Met were added to the BM-DCs as suspensions in PBS in a ratio of 
approximately 25:1, respectively. After 45 minutes of incubation unbound/non-
internalised E. coli cells were washed off (2x PBS) and medium was replaced. At 
the indicated time points cells were fixed in 4% PFA for 15 minutes. Until further 
analysis cells were kept in PBS at 4°C. When all slides were collected, fixed cells 
were incubated for 30 minutes with blocking buffer (1% BSA, 1% gelatin cold 
water fish skin), for 1 h with click cocktail (0.1 M HEPES pH 7.3, 1  mM CuSO4, 
1 0  mM sodium ascorbate, 1 mM THPTA ligand, 1 0  m M  a m i n o - g u a n i d i n e ,  
5  µM AlexaFluor-488 Alkyne (Invitrogen)), O/N with anti-actin antibody (abcam), 
1 h with goat anti-rabbit AlexaFluor-568 (Invitrogen) and DAPI (1 µg/ml). After the 
staining procedures chambers were removed and cells were covered with a small 
drop of 50% glycerol, after which a coverslip was mounted over the grid. 
Coverslips were fixed using Scotch Pressure-Sensitive Tape. Samples were 
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Bioorthogonal labelling on cryosections 
Samples were prepared for cryosectioning as described elsewhere.41 Briefly, 
BM-DCs were fixed for 24 h in freshly prepared 2% PFA in 0.1 M phosphate 
buffer. Fixed cells were embedded in 12% gelatin (type A, bloom 300, Sigma) 
and cut with a razor blade into 0.5 mm3 cubes. The sample blocks were infiltrated 
in phosphate buffer containing 2.3 M sucrose for 3 h. Sucrose-infiltrated sample 
blocks were mounted on aluminum pins and plunged in liquid nitrogen. The 
frozen samples were stored under liquid nitrogen. 
 
Ultrathin cell sections were obtained as described elsewhere. Briefly, the frozen 
sample was mounted in a cryo-ultramicrotome (Leica). The sample was trimmed 
to yield a squared block with a front face of about 300 x 250 μm (Diatome 
trimming tool). Using a diamond knife (Diatome) and antistatic device (Leica) a 
ribbon of 150 nm thick sections was produced that was retrieved from the 
cryochamber with a droplet of 1.15 M sucrose containing 1% methylcellulose. 
Obtained sections were transferred to a specimen grid previously coated with 
formvar and carbon. Grids were additionally coated as indicated with either 100 
nm TetraSpeck beads or 100 nm FluoroSpheres (blue) carboxylate-modified 
(350/440) (Life Technologies). 
 
To further improve the structural integrity of the ultrathin cryosections a  novel 
micromanipulator (Manip, Diatome) was used that was mounted on the 
cryochamber of the ultramicrotome.42 This device facilitated section retrieval 
from the cryochamber and resulted in less overstretching of the sections during 
thawing.43 
 
Sections were labelled as follows; thawed cryosections on an EM grid were left for 
30 minutes on the surface of 2% gelatin in phosphate buffer at 37°C. 
Subsequently grids were incubated on drops of PBS/glycine and PBS/glycine 
containing 1% BSA. Grids were then incubated on top of the ccHc-cocktail (0.1 
M HEPES pH 7.3, 1  mM CuSO4, 1 0  mM sodium ascorbate, 1 mM THPTA ligand, 
1 0  m M  a m i n o - g u a n i d i n e ,  5  µM AlexaFluor-488 alkyne (Invitrogen) for 1 h 
and washed 6 times with PBS. Sections containing BM-DCs and Jurkat cells 







In case of additional immune-labelling against LAMP-1 grids were subjected to the 
following steps directly after the ccHc reaction. Grids were washed 5 times with 
PBS/glycine and blocked again with PBS/glycine containing 1% BSA after which the 
grids were incubated for 1 h with PBS/glycine 1% BSA supplemented with a rat 
anti-mouse LAMP-1 (BioLegend). Sections were subsequently washed 6 times 
with PBS, labelled with  DAPI (2 µg/ml) and finally washed again with PBS and 
aquadest. 
 
Microscopy and correlation 
The CLEM approach used was adapted from Vicidomini et al.44 Grids containing 
the sample sections were washed with 50% glycerol and placed on glass slides 
(pre- cleaned with 100% ethanol). Grids were then covered with a small drop of 
50% glycerol, after which a coverslip was mounted over the grid. Coverslips 
were fixed using Scotch Pressure-Sensitive Tape. Samples were imaged with a 
Leica TCS SP8 confocal microscope (63x oil lens, N.A.=1.4). Confocal microscopy 
was used as it allowed to make image stacks from the sections at different focus 
planes; this was convenient as the sections were found to be in different focus 
planes whilst placed between the glass slides and coverslip. Confocal stacks were 
deconvolved with theoretical point spread functions using Huygens Essential 
deconvolution software (SVI, Hilversum, Netherlands). After fluorescence 
microscopy the EM grid with sections was removed from the glass slide, rinsed in 
distilled water and  incubated for 5 minutes on droplets of  
unranylacetate/methylcellulose.  
 
Excess of  uranylacetate/methylcellulose was blotted away and grids were air-
dried. EM imaging was performed with a Tecnai 12 Biotwin transmission electron 
microscope (FEI) at 120 kV acceleration voltage. Tilt series for electron 
tomography were collected using Xplore3D (FEI Company) software. The angular 
tilt range was set from -60˚ to 60˚ with 2˚ increments, and an objective lens 
defocus of -2 µm at a magnification of 20 K (pixel size is 1 nm). Alignments of 
the tilt series and weighted-back projection reconstructions for tomography 
were performed using  IMOD software.45 
 
Correlation of confocal and EM images was performed in Adobe Photoshop 
CS6. In Adobe Photoshop, the LM image was copied as a layer into the EM image 
and made 50% transparent. Transformation of the LM image was necessary to 
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match it to the larger scale of the EM image. This was performed via isotropic 
scaling and rotation. Interpolation settings; bicubic smoother. Alignment at low 
magnification was carried out with the aid of nuclear DAPI staining in combination 
with the shape of the cells, at high magnification alignment was performed using 
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Towards Ultrastructural Imaging of Salmonella-Host Interactions 









The immune system is the defence mechanism that protects the human body 
against illness and infection. Through a series of steps called the immune 
response, it attacks pathogens and potentially harmful commensals. When rapid 
and effective, the infection will be eliminated quickly and disease will not occur. 
However, many bacterial pathogens have evolved strategies to subvert and 
exploit the immune response in order to enter and replicate in eukaryotic cells.  
 
A prime example of such a bacterial pathogen is Salmonella enterica (Salmonella). 
Salmonella is a Gram-negative facultative intracellular pathogen that infects both 
humans and animals.1 More than 2500 Salmonella serotypes exist, which can be 
broadly grouped in non-typhoidal and typhoidal.2 Non-typhoidal Salmonella 
serotypes cause localised gastrointestinal infections in healthy human adults, 
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whereas typhoidal serotypes have evolved to enter and exploit intestinal 
macrophages and cause life-threatening systemic infections.3, 4  
 
Typhoidal Salmonella establishes a systemic infection upon the temporal and 
spatial injection of bacterial proteins into macrophage cells.5 This temporal and 
coordinated delivery of effector proteins modulates the functions of the 
macrophage cell organelles and promotes Salmonella replication and its 
subsequent dissemination throughout the host.6 Salmonella can enter 
macrophages by several endocytic routes, which are triggered by the secretion of 
several effector proteins via both pathogenicity island 1 (SPI1) and non-SPI1 type 
III secretion systems (T3SS) (Figure 1, (1)).7 Once intracellular, Salmonella remains 
inside the spacious phagosome (SP) (Figure 1, (2)). This vacuolar compartment 
shrinks over minutes to hours to form an adherent membrane around one or 
more bacteria, which is then referred to as the Salmonella-containing vacuole 
(SCV) (Figure 1, (3)). Upon the injection of effector proteins Salmonella modulates 
the interaction of the SCV with the endocytic environment and the ER-Golgi 
network and as such ensures the maturation of the SCV and its own replication 
(Figure 1, (4)).3  
 
Understanding the mechanisms by which Salmonella modulates and interacts 
with host cell organelles is thus of key importance for the understanding of 
Salmonella-virulence mechanisms in the development of systemic Salmonella 
infections.6 To unravel these mechanisms injected and secreted bacterial proteins 
need to be labelled and traced.  
 
Proteome-wide labelling of injected and secreted bacterial proteins can be 
established using bioorthogonal non-canonical amino acid tagging (BONCAT). 
With BONCAT bioorthogonally functionalised amino acid analogs such as 
azidohomoalanine (Aha) and homopropargylglycine (Hpg) are incorporated in the 
proteomes of prokaryotic and eukaryotic cells (Figure 2A). These bioorthogonal 
amino acid analogs are incorporated by wild-type methionyl-tRNA synthetase 
(metRS) at the sites where naturally methionine amino acids are incorporated. 
After incorporation, bioorthogonally functionalised amino acids can be labelled 
with a detection group using chemical ligation (Figure 2C).8, 9  
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Recently, Grammel et al. reported that the BONCAT labelling strategy can even be 
used to selectively label and study the proteome wide expression levels of 
bacterial pathogens inside mammalian immune cells.8-12 By mutating the 
methionyl-tRNA synthetase (NLL-MetRS) of bacteria, non-canonical amino acid 
such as azidonorleucine (ANL) and 2-aminoocytynoic acid (AOA) (Figure 2B) were 
specifically incorporated in Salmonella Typhimurium and Yersinia enterocolitica 
whilst present in the environment of a host cell. Recently, Mahdavi et al. reported 
that this bioorthogonal labelling approach even enabled the identification of 
distinct secretion profiles for intracellular and extracellular bacteria, and showed 
that it allows the analysis of the temporal order of bacterial protein expression 
during different stages of infection.11, 13  
 
Figure 1: Schematic overview of interactions between Salmonella and host macrophage cells. 
Salmonella gets internalised by endocytosis upon secretion of effector proteins trough the T3SS (1). 
Subsequently Salmonella is enclosed in a spacious phagosome (SP) that is formed by membrane 
ruffles (2). Later, the phagosome fuses with lysosomes, acidifies and shrinks to become adherent 
around the bacterium. This is called the Salmonella-containing vacuole (SCV) (3). Upon the injection 
of effector proteins through the T3SS Salmonella modulates the interaction of the SCV with the 
endocytic environment and the ER-Golgi network and as such ensures the maturation of the SCV 





Figure 2: BONCAT for the identification of secreted bacterial effector proteins. (A) Structures of 
natural amino acid Met (1) and bioorthogonal amino acid analogs Aha (2) and Hpg (3) that can all be 
charged to tRNAMet by the wild-type MetRS. (B) Structure of Anl, which can be utilised only by a 
mutant synthetase like MetRSNLL and can therefore be incorporated cell-specifically in the bacterial 
proteome during infection. (C) Reaction scheme of Cu-catalyzed cycloaddition reaction between 
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BONCAT is thus a very powerful tool to unravel the temporal expression of 
Salmonella effector proteins. However, to investigate the interaction of these 
effector proteins with the host-environment, tools are needed that allow for their 
detection within the context of the hostcell. Recently, an approach was reported 
that enables the visualisation of BONCAT-labelled bacteria in the context of a host 
cell with correlative light and electron microscopy (CLEM).14 This correlative 
transmission electron microscopy (TEM) technique allows for the wide field 
navigation to areas of interest with fluorescence microscopy and provides narrow 
field high-resolution information on the interior of the cell with TEM, and would 
thus allow for the visualisation of BONCAT-labelled Salmonella in the context of 
host cell organelles. However, the resolution of the fluorescence detection within 
this strategy, which is around 250 nm15, is not sufficient to unravel the existence 
of secreted virulence factors, which can be around 2-20 nm in diameter.16  
 
Recent developments in the field of CLEM have shown that upon implementing 
super-resolution imaging in CLEM, the detection resolution of fluorescent probes 
can be improved 10-fold, resulting in a more accurate and sensitive ultrastuctural 
localisation of fluorescent labels.17  Since its initial inception it was shown that, 
depending on the research question, super-resolution imaging strategies can be 
combined with TEM in various ways.18 It has been reported that upon lowering 
osmium tetroxide (OsO4) concentrations and optimisation of embedding resin, 
fluorescence quenching could be prevented and fluorescence was preserved. This 
sample preparation technique was used with both PALM (photoactivated 
localisation microscopy)17 and STED (stimulated emission depletion) 
microscopy.19-21 Another example described the use of PALM, or STORM 
(stochastic optical reconstruction microscopy)22, after Tokuyasu sectioning and 
subsequent OsO4 contrast enhancement prior to scanning electron microscopy 
measurements.23, 24 Since this latter technique uses Tokuyasu sample preparation 
as also reported for the BONCAT-CLEM strategy, it could be implemented in the 
CLEM strategy for the visualisation of secreted virulence factors. The aim of this 
study is therefore to apply the BONCAT-CLEM strategy for the imaging of 
BONCAT-labelled Salmonella virulence factors upon implementation of STORM 









In order to monitor Salmonella-host interactions with bioorthogonal amino acid 
tagging and CLEM, it was first tested whether bioorthogonal amino acids could be 
incorporated into the Salmonella proteome without the need of tRNA/tRNA 
synthetase engineering. To this end, the incorporation of the bioorthogonal amino 
acid Hpg into the bacterial proteome was monitored, analogous to the method 
outlined for E. coli in Chapter 3.25   
 
It was decided to explore the incorporation of Hpg into the Salmonella model 
bacterium S. Typhimurium, as it represents a useful model to characterise the 
molecular mechanisms that underpin the interactions between thyphoidal 
Salmonella species and phagocytic cells.3 Incorporation into the proteome was 
optimised with respect to cell viability and incorporation levels as assessed using 
SDS-PAGE analysis. In line with previous findings, extended incubation times 
resulted in reduced viability (Figure 3A), suggesting negative effects on protein 
expression upon prolonged exposure to bioorthogonal amino acids.10, 14 
Surprisingly, lowering the concentration of the bioorthogonal amino acid Hpg 
resulted in a higher incorporation level (Figure 3B). Thus, optimal conditions in 
terms of viability and incorporation levels were 30 minutes incubation with 0.4 
mM Hpg, and these conditions were used for all further imaging studies. 
 
To address whether the alkyne-S. Typhimurium bacteria could be imaged within a 
host cell using bioorthogonal labelling and confocal microscopy analysis, mouse 
bone marrow-derived dendritic cells (BM-DCs) were incubated with alkyne-
modified S. Typhimurium expressing the fluorescent protein DsRed.26 
Subsequently, cells were washed, fixed and labelled with AlexaFluor-488 azide 
using the optimised copper-catalysed Huisgen cycloaddition (ccHc) reactions 
described in Chapter 3 of this thesis.14 Confocal analysis revealed colocalisation of 
the DsRed-expressing S. Typhimurium and the bioorthogonal AlexaFluor-488 label 
(Figure 4). However, the signal of the AlexaFluor-488 was faint, which is most 
probably a result of the presence of endogenous Met that competes with Hpg for 
its incorporation. Despite this competition, these results show that the alkyne-S. 
Typhimurium  bacteria can be labelled detectably with AlexaFluor-488-azide in the 
environment of a host cell using a ccHc reaction.  
- 96 -
Towards Ultrastructural Imaging of Salmonella-Host Interactions  
using Bioorthogonal Labelling and Super-Resolution CLEM 
 
 
Figure 3: Hpg incorporation in S. Typhimurium A) S. Typhimurium cells were grown to an OD600 of 
0.3-0.5. Cultures were then incubated with the indicated Hpg or Met concentrations. OD600 were 
measured at indicated time points and relative generations were calculated (first generation was 
set at 1 at timepoint 0). B) Top: Fluorescence gel of AlexaFluor-647 alkyne-labelled S. Typhimurium 
cells grown in the presence of the indicated concentrations of Hpg and Met. Bottom: Coomassie-










Figure 4: Confocal microscopy of BM-DCs incubated with alkyne-S. Typhimurium. BM-DCs were 
incubated with alkyne-S. Typhimurium  expressing DsRed. After a 45 minutes pulse cells were 
washed and fixed. Cells were subsequently labelled with AlexaFluor-488 azide (green = AlexaFluor-
488) and DAPI. A) merged channels, B) DAPI only, C) DsRed, D) AlexaFluor-488 azide. A.i-D.i) low 
magnification overview, A.ii-D.ii) high magnification overview.  
 
For analysis of alkyne-S. Typhimurium  bacteria on ultrastructures, 
bioorthogonally tagged S. Typhimurium has to be specifically labelled after 
Tokuyasu sample preparation and cryosectioning. To test the feasibility of this 
approach BM-DCs were again incubated with alkyne-S. Typhimurium and 
subjected to Tokuyasu sample preparation: after cryosectioning, the samples 
were transferred to an EM grid and labelled with AlexaFluor-488-azide using a 
ccHc-reaction. These sections were then imaged in the confocal microscope. This 
revealed a very low signal-to-noise ratio of the AlexaFluor-488-azide (Figure 5A), 
in line with the whole cell confocal microscopy findings.  
 
In an attempt to increase the intensity of fluorescence of the bioorthogonal 
handles, an additional labelling step was included to enhance the signal. First the 
sections were incubated with anti-AlexaFluor-488 IgG, which was then visualised 
using the IgG-binding protein A conjugated with-AlexaFluor-647. This approach 
resulted in an improvement of the signal-to-noise ratio and provided sufficient 
fluorescence to perform CLEM analysis (Figure 5B). After this successful confocal 
imaging, the sections were embedded in methylcellulose with uranylacetate and 
subjected to EM imaging. Correlation of the confocal and EM images was 
A.i B.i C.i D.i 
A.ii B.ii C.ii D.ii 
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performed using nuclear DAPI stain (Figure 6). Images were successfully 
correlated and morphological information obtained from the EM images showed 
that the alkyne-positive foci located on intact S. Typhimurium, as well as smaller 
non double-membrane containing structures (Figure 6D/E, yellow arrows). These 
results show that, upon use of a combination of bioorthogonal labelling and 
CLEM, ultrastructural information of S. Typhimurium and of the host phagocyte 
could successfully be obtained.  
 
Figure 5: Protein A-AlexaFluor-647 enhancement of bioortohogonal labelling. BM-DCs were 
incubated with alkyne-S. Typhimurium and washed with PBS to remove unbound/non-internalised 
S. Typhimurium. Cells were fixed, subjected to Tokuyasu sample preparation and cryosectioned into 
75 nm sections. A.i) Sections were reacted with AlexaFluor-488 azide using ccHc-conditions (green), 
and stained with DAPI (blue). B.i) To enhance the fluorescence signal of the bioorthogonal label 
sections were additionally labelled with Protein A-AlexaFluor-647 (green) using a rabbit anti 








Figure 6: CLEM imaging of phagocytosed alkyne-S. Typhimurium. BM-DCs were incubated with 
alkyne-S. Typhimurium and washed with PBS to remove unbound/non-internalised S. Typhimurium. 
Cells were fixed and subjected to Tokuyasu sample preparation and cryosectioned into 75 nm 
sections. Sections were reacted with AlexaFluor-488 azide using ccHc-conditions (green) and stained 
with DAPI (blue). The fluorescence signal of the AlexaFluor-488 was enhanced with protein A 
AlexaFluor-647 using a rabbit anti-AlexaFluor-488 antibody. DAPI staining was used for correlation 
purposes. A) low magnification confocal image, B) high magnification confocal image, C) CLEM image 
of B correlated with EM image, D) detail of C, E) detail of D. Yellow arrows indicate label that derived 
from alkyne-S. Typhimurium. Scale bar 500 nm. 
 
The resolution of the fluorescence signal that was used for the correlation of the 
bioorthogonal signal results in accuracies around 250 nm, due to the van Abbe 
diffraction limit of visible light. Since the main envisaged goal of the method 
development was to reveal the location of secreted virulence factors that are 
around 2-20 nm in size16, the detection level of the fluorescence signal had to be 
improved. It was therefore explored whether the photoactivated localisation 
microscopy (PALM)-CLEM imaging of fluorescent proteins initially reported by 
Betzig and co-workers17, could be modified to the use of detecting the 
A B C 
D E 
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bioorthogonal labels. For this the related Nikon N-STORM was explored on the 
Tokuyasu-sections that were previously imaged by confocal microscopy (Figure 6). 
Sections were now labelled with AlexaFluor-647 and embedded between a glass 
slide and coverslip with a glucose oxidase (GLOX) buffer. The use of STORM 
imaging on the sample sections resulted in a drastic improvement of both the 
accuracy and detection levels of the fluorescently labelled alkyne-S. Typhimurium 
(Figure 7). Additionally, distinctions in label intensities could be observed within 
the individual bacteria. Since alkyne handles were incorporated prior to infection, 
non-labelled regions within the bacteria might represent regions where newly 
synthesised, untagged, proteins are formed.27   
 
Figure 7: Super-resolution N-STORM image of 75 nm cryosection of BMDCs incubated with alkyne-
S. Typhimurium. BM-DCs were incubated with alkyne-S. Typhimurium and washed with PBS to 
remove unbound/non-internalised S. Typhimurium. Cells were fixed and subjected to Tokuyasu 
sample preparation and cryosectioned into 75 nm sections. Sections were reacted with AlexaFluor-
647 azide using ccHc-conditions (red). A.i) Wide field low resultion image of alkyne-S. Typhimurium 
A.ii) Super resolution N-STORM image of alkyne-S. Typhimurium. Scale bar: 500 nm. 
 
Sample sections were subsequently treated as for the previously reported CLEM 
strategy and EM structure were analysed (Figure 8). It seemed that STORM 
imaging did not affect the appearance of the ultrastructures. Membranes were 
intact and no structural alterations could be observed between STORM-imaged 
regions compared to non-imaged ones. Moreover, host cell organelles were still 
recognisable by their distinct morphological appearances. Upon correlation of the 






Moreover, small labels surrounding the bacteria were present on small structures 
with a diameter of around 10-20 nm, which were both present on membranes of 
vesicular host structures and were seemingly unattached within the spacious 
phagosome.  
 
Figure 8: Super-resolution N-STORM-CLEM image of 75 nm cryosection of BMDCs incubated with 
alkyne-S. Typhimurium. BM-DCs were incubated with alkyne-S. Typhimurium and washed with PBS 
to remove unbound/non-internalised S. Typhimurium. Cells were fixed and subjected to Tokuyasu 
sample preparation and cryosectioned into 75 nm sections. Sections were reacted with AlexaFluor-
647 azide using ccHc-conditions (red). A.i) Example 1 of super-resolution N-STORM image of alkyne-
S. Typhimurium. A.ii) super-resolution CLEM image of A.i. B.i) Example 2 of super-resolution N-
STORM image of alkyne-S. Typhimurium. B.ii) super-resolution CLEM image of B.i. Arrows indicate 
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Conclusion  
The results presented show that upon implementation of STORM imaging in a 
CLEM setting, BONCAT-labelled S. Typhimurium can be imaged within the context 
of the host cell with high sensitivity and accuracy. This strategy has great potential 
to further elucidate the temporal and spatial injection of Salmonella virulence 
factors and their interactions with host organelles. In the presented experimental 
setup the S. Typhimurium bacteria were BONCAT labelled prior to their encounter 
with phagocytic host cells. This setup primarily allows for the monitoring of 
effector protein secretion during early stages of infection. However, since 
strategies have been reported to specifically BONCAT label a bacterium whilst 
interacting with a host cell, this imaging approach would also allow monitoring of 
effector protein secretion during later stages of infection.11 Moreover, due to the 
broad applicability of BONCAT labelling, this strategy can also be combined with 
several mutant strains that have been shown to have attenuated virulence. In this 
fashion information can be obtained on the host-interaction and secretion 
patterns of these attenuated strains. In addition, the site-specific incorporation of 
bioorthogonal handles in virulence factors of interest would even allow for a more 
targeted CLEM-imaging approach between virulence factors and host cell 
organelles.28 For example, a single virulence factor of interest can be specifically 
BONCAT-labelled and using the STORM-CLEM approach quantitative information 































Salmonella Typhimurium  culturing conditions  
Salmonella Typhimurium  expressing DsRed26, 31, 32 were grown overnight at 37°C 
in Lysogeny Broth (LB) medium. The following day cultures were diluted 1:33 in 
LB medium and grown at 37°C till an OD
600 between 0.3-0.5. Subsequently cells 
were collected and resuspended in Selenomet medium (Molecular Dimensions) 
and supplemented with either 0.04, 0.4 or 4 mM Homopropargylglycine (Hpg) 
(Chiralix) or 4 mM Methionine (Met) (Sigma-Aldrich). After 3 0 ,  6 0  a n d  1 2 0  
m i n u t e s  OD600  were measured and cells were collected by centrifugation for 
gel analysis and bone marrow dendritic cell (BM-DC) infection experiments. 
Throughout culturing, cultures were supplemented with 100 µg/ml Ampicillin. 
 
Mammalian cell culture conditions 
Mouse BM-DCs were generated from B57BL/6 mice bone marrow essentially as 
described33
 
with some modifications. Briefly, bone marrow was flushed from 
femurs and tibia and cells were cultured in IMDM (Sigma Aldrich) supplemented 
with 8% heat-inactivated fetal calf serum, 2 mM L-glutamine, 20 μM 2-
mercaptoethanol (Life Technologies), penicillin 100 l.U./mL and streptomycin 
50 μg/mL in the presence of 20 ng/mL GM-CSF (ImmunoTools). Medium was 
replaced on day 3 and 7 of culture and the cells were used between days 10 and 
13.  
 
S. Typhimurium expressing DsRed and cultured in the presence of 0.4 mM Hpg for 
30 minutes were added to the BM-DCs as suspensions in PBS at a multiplicity of 
infection (MOI) of 50. After 45 minutes of incubation unbound/non-internalised S. 
Typhimurium cells were washed away (2x PBS) and medium was replaced. 




At the indicated time points S. Typhimurium were collected and cells were lysed 
with lysis buffer (50 mM HEPES pH 7.3, 150 mM NaCl and 1% NP-40) and 
incubated on ice for 1 h. Subsequently protein concentrations were determined 
with a Quibit 2.0 fluorimeter (Life Technologies), after which 20 µg of the protein 
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was incubated for 1 h with copper catalysed Huisgen cycloaddition (ccHc)-cocktail 
(0.1 M HEPES pH 7.3, 1 mM CuSO4, 10 mM sodium ascorbate, 1 mM THPTA ligand, 
10 mM amino-guanidine, 5 µM AlexaFluor-647 azide (Invitrogen)). Samples were 
then resuspended in 4x SDS Sample buffer (250 mM TrisHCl pH 6.8, 8% w/v SDS, 
40% glycerol, 0.04% w/v bromophenolblue, 5% 2-mercaptoethanol) and 
incubated at 100°C for 5 minutes. After the  samples  were  run  through a  
Hamilton syringe  multiple  times  to  shear genomic DNA, samples were subjected 
to SDS-PAGE. Gels were then directly imaged with a Biorad Universal Hood III for 
in-gel visualisation of the fluorescent labelling. As a loading control gels were 
stained with Coomassie Brilliant Blue. PageRuler Plus Prestained Protein Ladder 
(Thermo Scientific) was used as a protein standard. 
 
Whole-cell confocal microscopy 
BM-DCs were seeded (7 x 104) on a 12 well removable chamber slide (Ibidi) and 
left to grow O/N. The following day S. Typhimurium expressing DsRed and 
cultured in the presence of 0.4 mM Hpg for 30 minutes were added to the BM-
DCs as suspensions in PBS at an MOI of 50. After 45 minutes of incubation 
unbound/non-internalised S. Typhimurium were washed away (2x PBS) and cells 
were fixed in 4% PFA for 15 minutes. Until further analysis cells were kept in PBS 
at 4°C. Fixed cells were incubated for 30 minutes with blocking buffer (1% BSA, 1% 
gelatin cold water fish skin, 0.3% Triton X-100), for 1 h with click cocktail ((0.1 M 
HEPES pH 7.3, 1  mM CuSO4, 1 0  mM sodium ascorbate, 1 mM THPTA ligand, 
1 0  m M  a m i n o - g u a n i d i n e ,  5  µM AlexaFluor-647 Azide (Invitrogen)) and 
DAPI (1 µg/ml). After the staining procedures chambers were removed and cells 
were covered with a small drop of 50% glycerol, after which a coverslip was 
mounted over the grid. Coverslips were fixed using Scotch Pressure-Sensitive 
Tape. Samples were imaged with a Leica TCS SP8 confocal microscope (63x oil 
lens, N.A.=1.4).  
 
Bioorthogonal labelling on cryosections 
Samples were prepared for cryosectioning as described elsewhere34. Briefly, 
BM-DCs infected with S. Typhimurium were fixed for 24 h in freshly prepared 2% 
PFA in 0.1 M phosphate buffer. Fixed cells were embedded in 12% gelatin 
(type A, Bloom 300, Sigma) and cut with a razor blade into 0.5 mm3 cubes. The 





3 h. Sucrose-infiltrated sample blocks were mounted on aluminum pins and 
plunged in liquid nitrogen. Frozen samples were stored under liquid nitrogen. 
 
Ultrathin cell sections were obtained as described elsewhere.34 Briefly, the 
frozen sample was mounted in a cryo-ultramicrotome (Leica). The sample was 
trimmed to yield a squared block with a front face of about 300 x 250 μm 
(Diatome trimming tool). Using a diamond knife (Diatome) and antistatic device 
(Leica) a ribbon of 150 nm thick sections was produced that was retrieved from 
the cryochamber with a droplet of 1.15 M sucrose containing 1% methylcellulose. 
Obtained sections were transferred to a specimen grid previously coated with 
formvar and carbon. Grids were additionally coated as indicated with 
carboxylate-modified fluorescent fiducial beads (350/440)(Life Technologies). 
 
Sections were labelled as follows: thawed cryosections on an electron microscopy 
(EM) grid were left for 30 minutes on the surface of 2% gelatin in phosphate 
buffer at 37°C. Subsequently grids were incubated on drops of PBS/glycine and 
PBS/glycine containing 1% BSA. Grids were then incubated on top of the ccHc- 
cocktail (0.1 M HEPES pH 7.3, 1 mM CuSO4, 10 mM sodium ascorbate, 1 mM 
THPTA ligand, 10 mM amino-guanidine, 5 µM AlexaFluor-488 Azide or AlexaFluor-
647 Azide (Invitrogen) for 1 h and washed 6 times with PBS. In preparation for 
confocal microscopy the grids were blocked again with PBS/glycine containing 1% 
BSA after which the grids were incubated for 1 h with PBS/glycine 1% BSA 
supplemented with an AlexaFluor-488 antibody (Invitrogen). After washing with 
PBS/Glycine and blocking with PBS/glycine 0.1 % BSA, grids were incubated for 20 
minutes on PBS/Glycine 1% BSA supplemented with AlexaFluor-647 Protein A 
(Invitrogen) to enhance the fluorescence signal. Sections were then labelled with  
DAPI (2 µg/ml), and additionally washed with PBS and aquadest.  
 
Microscopy and correlation 
The correlative light and electron microscopy (CLEM) approach used was adapted 
from Vicidomini et al.35 Grids containing the sample sections were washed with 
50% glycerol and placed on glass slides (pre-cleaned with 100% ethanol). Grids 
were then covered with a small drop of 50% glycerol after which a coverslip was 
mounted over the grid. Coverslips were fixed using Scotch Pressure-Sensitive 
Tape. Samples were imaged with a Leica TCS SP8 confocal microscope (63x oil 
lens, N.A.=1.4). Confocal microscopy was used as it allowed to make image stacks 
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from the sections at different focus planes; this was convenient as the sections 
were found to be in different focus planes whilst placed between the glass slides 
and coverslip.  
 
In case of STORM imaging grids containing the sample sections were washed with 
glucoseoxidase (GLOX) buffer (100 µl PBS, 20 µl 50% glucose, 20 µl 1M MEA 
(monoethanolamine) and 2µl GLOX (0.7 mg/ml GLOX, 5 mg/ml catalase in PBS) 
supplemented with 30% glycerol (60 µL) and placed on glass slides. Grids were 
then covered with a small drop of GLOX buffer, after which a coverslip was 
mounted over the grid. STORM images were acquired using a Nikon N-STORM 
system configured for total internal reflection fluorescence (TIRF) imaging. 
Excitation inclination was tuned to adjust focus and to maximise the signal-to-
noise ratio. AlexaFluor-647 was excited illuminating the sample with a 647 nm 
(∼160 mW) laser line built into the microscope. Fluorescence was collected by 
means of a Nikon 100x, 1.4 NA oil immersion objective and passed through a 
quad-band-pass dichroic filter (97335 Nikon). 20,000 frames were acquired for the 
647 channel. Images were recorded onto a 256 × 256 pixel region (pixel size 160 
nm) of a CMOS camera. STORM images were analysed with the STORM module of 
the NIS element Nikon software.30  
 
After fluorescence or STORM microscopy the EM grid with the sections was 
removed from the glass slide, rinsed in distilled water and  incubated for 5 
minutes on droplets of  uranylacetate/methylcellulose. Excess of  
uranylacetate/methylcellulose was blotted away and grids were air-dried. EM 
imaging was performed with a Tecnai 12 Biotwin transmission electron 
microscope (FEI) at 120 kV acceleration voltage.36 
 
Correlation of confocal and EM images was performed in Adobe Photoshop 
CS6. In Adobe Photoshop, the light microscopy (LM) image was copied as a layer 
into the EM image and made 50 % transparent. Transformation of the LM image 
was necessary to match it to the larger scale of the EM image. This was performed 
via isotropic scaling and rotation. Interpolation settings; bicubic smoother. 
Alignment at low magnification was carried out with the aid of nuclear DAPI 
staining in combination with the shape of the cells; at high magnification 
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Towards Ultrastructural Imaging of Enzyme Activity with  










Enzymes are proteins that are involved in the metabolic pathways of living 
systems, and catalyse chemical reactions that modify, take apart and construct 
biomolecules. Their activity is regulated by post-translational modifications, 
protein-protein interactions and/or endogenous small-molecule inhibitors, and as 
a consequence their expression levels do not necessarily correlate with their 
activity.1 Labelling methods such as genetically-encoded reporter proteins and/or 
antibodies can therefore not be used to obtain information on their active 
populations.2 To this end chemical probes termed activity-based probes (ABPs) 
have been developed, which target the active site of an enzyme and only label its 
catalytically active form.3 ABPs consist of three essential structural elements; (1) a 
recognition element, (2) a reactive group or ‘warhead’ and (3) a detectable group. 
The recognition element is recognised as substrate by the enzyme of interest and 
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ensures the selectivity of the ABP. The warhead ensures (covalent) binding of the 
ABP to the enzyme of interest upon reaction with the catalytically-active amino 
acid residue of the enzyme. The detectable group can either be a bioorthogonal 
ligation handle or a reporter (e.g. biotin or a fluorophore) (Figure 1A/B, 
respectively).2 If the detectable group is a bioorthogonal ligation handle, the 
strategy is referred to as two-step ABP labelling and the modification of the ABP 
takes place after the ABP has reacted with its target enzyme (Figure 1A). 
Bioorthogonal ligation handles are mostly azide- or alkyne moieties and can be 
ligated to a fluorescent group or an affinity handle depending on the experimental 
setup. When the detectable group itself is a reporter moiety, the ABP labelling 
strategy is referred to as direct ABP labelling, as enzymes are directly labelled with 
the ABP and can be directly visualised or isolated (Figure 1B). The main advantage 
of this strategy is that no additional labelling steps are necessary; however, the 
direct attachment of reporter groups may result in a lower binding affinity and/or 
specificity of the ABP.4, 5  
 
Figure 1: Two-step and direct labelling of enzymes with ABPs. A) The installation of a chemical 
reporter on active enzyme populations can be achieved upon use of two-step ABPs. Two-step ABPs 
consist of a warhead, recognition element and a chemical ligation handle. B) Direct ABPs consist of a 





Ultrastructural Imaging of Enzyme Activity with Correlative Light and Electron Microscopy 
 
Over the past decades, a large number of ABPs have been developed that enabled 
the identification and monitoring of enzyme activity in various disease states.3, 6-8 
Moreover, fluorescence imaging of enzyme activity with ABPs has yielded valuable 
information on subcellular enzyme localisation.9, 10 For example, imaging of 
cathepsin S activity has revealed the existence of distinct populations of cathepsin 
S-positive vesicles in bone marrow-derived immune cells.10 However, these 
imaging studies did not reveal any information on the cellular ultrastructures in 
which these active enzymes reside. To this end correlative light and electron 
microscopy (CLEM) imaging of active enzyme populations is explored in this 
chapter. It is demonstrated that CLEM imaging of both two-step and direct ABP 
labelling is feasible. With both strategies active populations of cysteine proteases 
could be identified in their ultrastructural cellular context. Moreover, upon 
combining direct ABP and CLEM the relative ultrastructural localisation of 
glucocerebrosidases and cathepsins could be revealed. 
 
Results  
CLEM imaging of enzyme activity with two-step ABPs 
To verify whether enzyme activity could be imaged with CLEM, a two-step ABP 
labelling sequence was implemented in the previously reported bioorthogonal on-
section labelling strategy.11 Mouse bone marrow-derived dendritic cells (BM-DCs), 
which express high levels of active cathepsins in their endolysosomal system, 
were incubated with the azide-functionalised ABP E-64 (Figure 2A). This 
irreversible cysteine protease inhibitor reacts selectively with cysteine proteases 
of the cathepsin family,12 that localise inside lysosomes and have the ability to 
degrade internalised matrix proteins.13 After incubation with E-64-azide, cells 
were washed, fixed and subjected to Tokuyasu sample preparation and 
cryosectioning. After cryosectioning, the E-64-azide incubated cells were labelled 
with an AlexaFluor-488 alkyne fluorophore using an on-section copper-catalysed 
Huisgen cycloaddition (ccHc) reaction (Figure 2B).11 This reaction ensured covalent 
attachment of the AlexaFluor-488 fluorophore to the E-64-azide probe (Figure 2C) 
and thus to the active population of cathepsins. Sections were subsequently 
imaged with confocal microscopy (Figure 2D, left upper panel), after which a 
methylcellulose/uranylacetate embedding step was performed. The sections were 
then EM imaged and correlation of the confocal and EM-images was performed 
using fluorescent electron-dense beads as reference markers (Figure 2D, lower 





The results show that E-64-azide could be successfully imaged using CLEM after 
on-section bioorthogonal ligation with an AlexaFluor-488 alkyne fluorophore. 
CLEM images show that the cysteine proteases of the cathepsin family -labelled 
by E-64- solely localised in membrane-limited lysosome-like structures of around 
50-250 nm in diameter (Figure 2D). The intensity of the fluorescent signal varied 
between these ultrastuctures, which possibly reflects the variations in cysteine 
protease activity within lysosomes.   
 
CLEM imaging of enzyme activity with a direct ABP 
To determine whether direct ABP labelling was also applicable with the CLEM 
protocol, CLEM imaging of a BODIPY-TMR functionalised E-64 probe was 
performed (Figure 3A). With exception of the bioorthogonal ligation step, CLEM 
images of the E-64-BODIPY-TMR treated BM-DCs were obtained according to the 
exact same protocol as for E-64-azide. The CLEM results show that upon labelling 
with E-64-BODIPY-TMR membrane-limited lysosome-like structures of around 50-
250 nm in diameter were marked cysteine protease-positive. E-64-BODIPY-TMR-
labelled structures were detected with varying fluorescence intensities, again 
indicating differences in cysteine protease activity throughout these organelles. 
These results are in accordance with the results obtained with the two-step 
protocol and indicate that with both direct and two-step E-64 variants 
ultrastructures can be labelled and CLEM-imaged in a similar fashion.  
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Figure 2: CLEM imaging of active populations of cysteine proteases in BM-DCs using a two-step ABP. 
A) Azide functionalised  E-64 probe. The recognition element of the E-64 probe contains a leucine 
side chain that ensures its selectivity to cysteine proteases. The warhead is an epoxide moiety that 
forms a stable covalent bond between enzyme and probe. The ligation handle is represented by an 
azide moiety that -after covalent interaction of the warhead with the enzyme- can be ligated to a 
detection group of interest upon a bioorthogonal ligation reaction. B) Bioorthogonal ligation 
strategy for the covalent attachment of a detection moiety on the azide functionality of the E-64 
probe. C) Product formed after ligation of the E-64-azide with a AlexaFluor-488 fluorophore. D) BM-
DCs were incubated for 2 h with 10 µM E-64-azide. Cells were fixed in 2% PFA, subjected to 









AlexaFluor-488 alkyne (green) using ccHc-conditions and DAPI (blue). DAPI staining and blue fiducials 
were used for correlation purposes. D) (Upper left) Confocal microscopy image of sample section; 
scale bar 5 µm. D) (Lower left) CLEM image obtained from overlay of confocal and EM pictures; scale 
bar 2 µm. D) (Right) High magnification detail showing the following structures: M, mitochondria; N, 
nucleus; G, Golgi. Scale bar 500 nm .  
 
Figure 3: CLEM imaging of active populations of cysteine proteases in BM-DCs using a direct ABP. A) 
BODIPY-TMR-functionalised  E-64 probe. B) BM-DCs were incubated for 2 h with 10 µM E-64-
BODIPY-TMR (red). Cells were fixed in 2% PFA, subjected to Tokuyasu sample preparation and 
cryosectioned into 75 nm sections. Sections were additionally stained with DAPI (blue). DAPI staining 
and blue fiducials were used for correlation purposes. B) (Upper left) Confocal microscopy image of 
sample section; scale bar 10 µm. B) (Lower left) CLEM image obtained from overlay of confocal and 
EM pictures; scale bar 5 µm. B) (Right) High magnification detail showing the following structures; M, 




Ultrastructural Imaging of Enzyme Activity with Correlative Light and Electron Microscopy 
 
Comparison of direct and two-step ABP labelling for the CLEM imaging  
To further analyse whether CLEM-sample preparation and CLEM-imaging 
influences the labelling efficiencies of the direct and two-step ABP E-64-BODIPY-
TMR was modified with an additional azide moiety (Figure 4).14 After ABP 
incubation and CLEM sample preparation the azide was functionalised with an 
AlexaFluor-488 fluorophore, using the exact same protocol as for the on-section 
labelling of the E-64-azide. In this manner, fluorescence signals of the direct and 
two-step ABP labelling strategies could be compared in one single experiment. 
The results show that both fluorescent signals label the exact same membrane-
limited lysosome-like structures (Figure 5). Colocalisation analysis of two signals 
resulted in a Pearson's R value of 0.82. Most probably this slightly lowered 
colocalisation is due to the high magnification of the confocal image, whereby 
chromatic aberration distortions of the fluorescent signals become visible. Overall 
these results corroborated that CLEM imaging of direct ABP labelling results in 
similar labelling efficiencies as CLEM imaging of two-step ABPs.  
 
Figure 4: Azide-functionalised E-64-BODIPY-TMR ABP14 conjugated to AlexaFluor-488 alkyne upon a 














































Figure 5: CLEM imaging of active populations of cysteine proteases in BM-DCs using direct and two-
step ABPs in a single experiment. BM-DCs were incubated for 2 h with 10 µM E-64-BODIPY-TMR-
azide (red). Cells were fixed in 2% PFA, subjected to Tokuyasu sample preparation and cryosectioned 
into 75 nm sections. Sections were labelled with DAPI (blue) and AlexaFluor-488 alkyne (green) using 
ccHc conditions. DAPI staining and blue fiducials were used for correlation purposes. (A.i) Confocal 
microscopy of direct ABP labelling of cysteine proteases (red); scale bar 500 nm. (B.i) CLEM image of 
direct ABP labelling of cysteine proteases (red); scale bar 500 nm. (A.ii) Confocal microscopy of two-
step ABP labelling of cysteine proteases (green), scale bar 500 nm. (B.ii) CLEM image of two-step 
ABP labelling of cysteine proteases (green), scale bar 500 nm. (A.iii) Confocal microscopy of 
simultaneous direct and two-step cysteine protease labelling, scale bar 500 nm. (B.iii) CLEM image of 
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Simultaneous CLEM imaging of glucocerebrosidase and cathepsins using ABP-
CLEM 
Glucocerebrosidase (GBA) is a lysosomal hydrolase that hydrolyses 
glucocerebrosides. Mutations in the GBA gene result in Gaucher disease, a 
lysosomal storage disease that is characterised by buildup of glucocerebrosides in 
lysosomes. GBA is a relatively short-lived enzyme in lysosomes15 and is subject to 
intra-lysosomal proteolytic degradation by cathepsins.16, 17 In case of the very 
common N370S GBA mutation in Caucasian Gaucher disease patients, resistance 
against intra-lysosomal proteolytic degradation is reduced. Inhibition of intra-
lysosomal turnover of GBA through cathepsin inhibition is therefore considered a 
therapeutic option for some Gaucher disease patients. Insight in the actual (co-
)localisation of reactive cathepsins and active GBA is therefore of great interest.  
 
Monitoring of GBA activity using ABPs has been described using a fluorophore-
functionalised cyclophellitol ABP (INHIBODY) that targets active variants of GBA 
(Figure 6).18 In a preliminary experiment to determine whether GBA and cathepsin 
co-localisation can be monitored using ABP-CLEM, HeLa and MelJuSo cells were 
labelled with both INHIBODY and E-64 probes. These cells were then subjected to 
the same imaging strategy described above for the CLEM imaging of E-64-BODIPY-
TMR-treated BM-DCs. CLEM images of labelled HeLa cells show that cysteine 
proteases and GBA co-localised in membrane-limited lysosome-like structures 
(Figure 7). This colocalisation of GBA and cysteine proteases in HeLa cells was 
confirmed with whole-cell confocal microscopy (Figure 8). In contrast to HeLa cells, 
conventional confocal microscopy and CLEM of dual-labelled MelJuSo cells 
showed only a partial colocalisation of cysteine proteases and GBA in lysosome-
like structures (Figure 9 and 10). Labelling of cysteine proteases was primarily 
associated with lysosome structures, indicated with solid arrows (Figure 10A/B). 
However, in case of GBA labelling, GBA was shown to be present in both 
lysosome-like cysteine protease-positive structures and cysteine protease-
negative ultrastructures. These cysteine protease-negative structures were found 
to be in very close proximity to the cysteine protease-positive structures, but had 
a distinct morphology. These results show that with direct ABP-CLEM multiple 
enzyme populations can be simultaneously imaged and reveal differences in the 






Figure 6: E-64-BODIPY-TMR ABP and INHIBODY-Cy5 ABP. E-64-BODIPY-TMR: The recognition 
element of the E-64 probe contains a leucine side chain that ensures its selectivity to cysteine 
proteases. The warhead is an epoxide moiety that forms a stable covalent bond between enzyme 
and probe. The reporter is a BODIPY-TMR fluorophore. INHIBODY-Cy5: the warhead is a 
cyclophellitol moiety that forms a stable covalent bond between the enzyme and the probe upon 
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Figure 7: CLEM imaging of cysteine proteases and glucocerebrosidases (GBAs) in HeLa cells using 
direct ABPs. HeLa cells were incubated for 2 h with 10 µM E-64-BODIPY-TMR (red) and 100 nM 
INHIBODY-Cy5 (green). Cells were fixed in 2% PFA, subjected to Tokuyasu sample preparation and 
cryosectioned into 75 nm sections. Sections were additionally stained with DAPI (blue). (Upper) 
CLEM image of cysteine proteases (red) and GBA (green) in HeLa cells; arrows indicate locations of 
cysteine proteases and GBA labelling. Scale bar 500 nm.  Lower left) High magnification detail of 
upper image showing ultrastructural context of E-64-BODIPY-TMR (red) labelling of cysteine 
proteases (arrows). M, mitochondria; N, nucleus, scale bar, 200 nm. Lower right) High magnification 
detail of upper image showing GBA labelling (arrows). Scale bar 200 nm. M, mitochondria; N, 





Figure 8: Whole cell and on-section confocal microscopy of HeLa cells incubated for 2 h with 10 µM 
E-64-BODIPY-TMR (red) and 100 nM INHIBODY-Cy5 (green). Cells were additionally stained with 
DAPI (blue). Scale bars, 25 µm. 
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Figure 9: Whole-cell and on-section confocal microscopy of MelJuSo cells incubated for 2 h with 
10 µM E-64-BODIPY-TMR (red) and 100 nM INHIBODY-Cy5 (green). Cells were additionally stained 














Ultrastructural Imaging of Enzyme Activity with Correlative Light and Electron Microscopy 
 
Figure 10 A/B: CLEM imaging of cysteine proteases and glucocerebrosidases (GBAs) in MelJuSo cells 
using direct ABP labelling. MelJuSo cells were incubated for 2 h with 10 µM E-64-BODIPY-TMR (red) 
and 100 nM INHIBODY-Cy5 (green). Cells were fixed in 2% PFA, subjected to Tokuyasu sample 
preparation and cryosectioned into 75 nm sections. Sections were additionally stained with DAPI 
(blue). Upper; CLEM image of cysteine proteases (red) and GBA (green) in HeLa cells; arrows indicate 
locations of cysteine proteases and GBA labelling. Scale bar 500 nm.  (Lower left) High magnification 
detail of upper image showing ultrastructural context of E-64-BODIPY-TMR labelling of cysteine 
proteases (red, arrows). M, mitochondria; N, nucleus, scale bar, 200 nm. (Lower right) High 
magnification detail of upper image showing GBA (green, arrows). M, mitochondria; N, nucleus; PM, 







In this chapter the first examples of ABP-CLEM are described. Firstly, populations 
of active cysteine proteases were imaged within the ultrastructural cellular 
context of dendritic cells using both a two-step and a direct ABP approach. It was 
shown that cysteine proteases reside inside membrane-limited lysosome-like 
structures of around 50-250 nm in diameter. It was additionally demonstrated 
that with both direct and two-step labelling enzyme activity can be labelled with 
high selectivity and efficiency, indicating that bioorthogonal labelling does not 
suffer from section penetration limits that have been reported for on-section 
antibody labelling strategies.19 
 
CLEM imaging of multiple enzyme classes showes that HeLa cells have a complete 
overlap in ultrastructural cellular location of cysteine proteases and GBA, whereas 
in MelJuSo cells a partial colocalisation could be observed. This partial 
colocalisation of GBA with E-64-BODIPY-TMR reactive cathepsins is not surprising 
as it is well established that there is a fundamental difference in the transport of 
newly synthesised cathepsins and of GBA to lysosomes. Cathepsins acquire 
mannose-6-phosphate (M6P) moieties in their N-linked glycans in the Golgi 
apparatus, which ensures the mannose-6-phosphate receptor (M6PR)-mediated 
transport to late endosomes/lysosomes.20 In sharp contrast, GBA enzymes depend 
on binding to the membrane protein LIMP-2 in the endoplasmic reticulum for 
their transport to lysosomes.21, 22 Upon LIMP-2 binding, newly formed GBA is 
transported to acidic late endosomes/lysosomes where low pH dependent 
dissociation of the complex occurs. It is therefore that distinct vesicular structures 
are reported to be involved in transport of cathepsins/M6PR and GBA/LIMP-2.20 
ABP-CLEM may provide new insights into the routing biology of these enzymes, 
and this information is crucial for research on enzyme activity in the lysosomal 
storage disorder Gaucher disease. It is foreseen that ABP-CLEM can be applied to 
monitor various Gaucher disease hallmarks and can be used for both diagnostic 
and therapeutic applications whereby information of GBA activity relative to the 









Mouse bone marrow derived dendritic cells (BM-DCs) were generated from 
B57BL/6 mouse bone marrow essentially as described23 with some modifications. 
Briefly, bone marrow was flushed from femurs and tibia and cells were cultured in 
IMDM (Sigma Aldrich) supplemented with 8% heat-inactivated fetal calf serum 
(FCS, Greiner), 2 mM L-glutamine, 20 μM 2-mercaptoethanol (Life Technologies), 
penicillin 100 l.U./mL and streptomycin 50 μg/mL in the presence of 20 ng/mL 
GM-CSF (ImmunoTools). Medium was replaced on day 3 and 7 of culture and the 
cells were used between days 10 and 13. BM-DCs were incubated for 2 h with E-
64-azide24 (final concentration of 10 μM) or E-64-TMR-azide after which the cells 
were washed with PBS and kept for 2 h in fresh medium.  
 
HeLa cells were cultured in DMEM (Gibco) supplemented with 7.5% FCS (Greiner). 
MelJuSo (human melanoma cell line) cells were cultured in IMDM (Sigma Aldrich) 
supplemented with 7.5% FCS (Greiner). HeLa and MelJuSo cells were  incubated 
for 2 h with 100 nM INHIBODY-Cy5 and 10 µM E-64-BODIPY-TMR from stock 
solutions in DMSO. After incubation cells were washed and subjected to further 
analysis.  
 
Whole cell confocal microscopy 
Cells were seeded (7 x 104) on a 12-well removable chamber slide (Ibidi) and left 
to grow O/N. The following day activity based probes (ABPs) were added at the 
indicated time and concentration. Cells were fixed in 4% PFA for 15 minutes and 
kept in PBS at 4 °C until further analysis. In case of click-labelling with AlexaFluor-
488, fixed cells were incubated for 30 minutes with blocking buffer (1% BSA, 1% 
gelatin cold water fish skin), for 1 h with click cocktail ((0.1 M HEPES pH 7.3, 1 mM 
CuSO4, 10 mM sodium ascorbate, 1 mM THPTA ligand, 10 mM ami n o - g u a n i d 
in e , 5 μM AlexaFluor-488 alkyne (Invitrogen)), and DAPI (1 µg/ml). In case of one-
step ABP labelling cells were only labelled with DAPI. After the staining 
procedures chambers were removed and cells were covered with a small drop of 
50% glycerol, after which a coverslip was mounted over the grid. Coverslips were 
fixed using Scotch Pressure-Sensitive Tape. Samples were imaged with a Leica TCS 







Bioorthogonal labelling on cryosections  
Samples were prepared for cryosectioning as described elsewhere.11, 25 Briefly, 
cells were fixed for 24 h in freshly prepared 2% PFA in 0.1 M phosphate buffer. 
Fixed cells were embedded in 12% gelatin (type A, Bloom 300, Sigma) and cut with 
a razor blade into 0.5 mm3 cubes. The sample blocks were infiltrated in 0.1 M 
phosphate buffer containing 2.3 M sucrose for 3 h. Sucrose-infiltrated sample 
blocks were mounted on aluminum pins and plunged in liquid nitrogen. The 
frozen samples were stored under liquid nitrogen. 
 
Ultrathin cell sections of 75 nm were obtained essentially as described 
elsewhere.11 Briefly, frozen samples were mounted in a cryo-ultramicrotome 
(Leica). Samples were trimmed to yield a squared block with a front face of about 
300 x 250 μm (Diatome trimming tool). Using a diamond knife (Diatome) and 
antistatic device (Leica) a ribbon of 75 nm thick sections was produced that was 
retrieved from the cryo-chamber with the lift-up hinge method.26 A droplet of 
1.15 M sucrose was used for section retrieval.  
 
Obtained sections were transferred to a specimen grid previously coated with 
formvar and carbon. Grids were additionally coated with 100 nm carboxylate-
modified FluoroSpheres (350/440) (Life Technologies).  
 
Sections that were click-labelled with AlexaFluor-488 were labelled as follows: 
thawed cryosections on an EM grid were left on the surface of 2% gelatin in 
phosphate buffer at 37°C for 30 minutes. Subsequently grids were incubated on 
drops of PBS/glycine and PBS/glycine containing 1% BSA. Grids were then 
incubated on top of the ccHc-cocktail (0.1 M HEPES pH 7.3, 1 mM CuSO4, 10 mM 
sodium ascorbate, 1 mM THPTA ligand, 10 mM amino-guanidine, 5 μM 
AlexaFluor-488 Alkyne (Invitrogen) for 1 h and washed 6 times with PBS. Sections 
were then labelled with DAPI (5 minutes) (2 µg/ml) and additionally washed with 
PBS and aquadest. In case of one-step ABP labelling cells were only labelled with 
DAPI. 
 
Microscopy and correlation 
The Correlative Light and Electron Microscopy (CLEM) approach used has been 
described elsewhere.11 Briefly, grids containing the sample sections were washed 
with 50% glycerol and placed on glass slides (pre- cleaned with 100% ethanol). 
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Grids were then covered with a small drop of 50% glycerol, after which a coverslip 
was mounted over the grid. Coverslips were fixed using Scotch Pressure-Sensitive 
Tape. Samples were imaged with a Leica TCS SP8 confocal microscope (63x oil lens, 
N.A.=1.4). After confocal microscopy the electron microscopy (EM) grid with the 
sections was removed from the glass slide, rinsed in distilled water and incubated 
for 5 min on droplets of an aqueous solution containing 2% methylcellulose and 6% 
uranyl acetate. Excess of methylcellulose/uranylacetate solution was blotted away 
and grids were air-dried. EM imaging was performed with a Tecnai 20 
transmission electron microscope (FEI) operated at 120 kV acceleration voltage.  
 
Correlation of confocal and EM images was performed in Adobe Photoshop CS6. 
In Adobe Photoshop, the fluorescence microscopy image was copied into the EM 
image as a layer and made 50% transparent. Transformation of the FM image was 
necessary to match it to the larger scale of the EM image. This was performed via 
isotropic scaling and rotation using interpolation settings; bicubic smoother. 
Alignment at low magnification was carried out with the aid of nuclear DAPI 
staining in combination with the shape of the fluorescently labelled cells. At high 
magnification alignment was performed using fiducial beads.27  
 
Colocalisation analysis 
The Pearson coefficient was determined on magnified confocal images (obtained 
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In this thesis the combinatorial use of bioorthogonal labelling and Electron 
Microscopy (EM)-based imaging techniques is explored to enable observations of 
specific molecular targets in their ultrastructural context within the cell. In 
chapter 1 the principles of EM imaging for biological research are discussed, 
including two different types of electron microscopes and various techniques to 
prepare specimens for transmission electron microscopy (TEM). Chapter 1 
additionally describes several labelling strategies that can be employed to identify 
biomolecules within EM-revealed structures. One of these approaches; correlative 
light and electron microscopy (CLEM) imaging, is explained by means of two 
generally used CLEM strategies; live-cell CLEM and on-section CLEM. 
In chapter 2 the importance and potential of bioorthogonal chemistry for CLEM 
imaging is emphasised. In this review an overview is given of frequently used 
bioorthogonal ligation strategies for imaging, including the copper-catalysed 




electron-demand Diels-Alder cycloaddition, and the photoclick reaction. Chapter 2 
further highlights the advances that have been made towards CLEM imaging of 
bioorthogonal functionality, including azide-modified gold particles, 
bioorthogonally-functionalised selenide/zinc sulphide core-shell quantum dots 
and bioorthogonally-functionalised fluorophores that are capable of 
photooxidising diaminobenzidine (DAB).  
Chapter 3 describes the development of two methods for EM detection of 
bioorthogonal labels. The first method is a gold labelling strategy that allows for 
the direct detection of bioorthogonal tags in the EM. The second method is a 
CLEM-based imaging method in which bioorthogonal tags are detected with 
fluorescence microscopy (FM), after which EM imaging is performed and 
images of both FM and EM are correlated. Both methods show that 
bioorthogonal labelling can be used to selectively label and localise the presence 
of bioorthogonal tags with EM in a non-homogenous sample of tagged and 
untagged E. coli bacteria.   
The methods described in chapter 3 are based on the ccHc-reaction. This 
chemical ligation strategy is well-known for its high reaction rate and selectivity 
and makes use of a very small bioorthogonal ligation handle, which minimally 
perturbs the structural integrity of the tagged biomolecule. Nevertheless, as 
stated in chapter 2, a variety of alternative labelling strategies exist, which might 
also be amenable to the bioorthogonal labelling of ultrathin cryosections. 
Investigation into these alternatives is desirable, since application of different 
bioorthogonal labelling strategies within one single specimen allows for the 
simultaneous bioorthogonal labelling of multiple different biomolecules.1 One of 
the most promising alternative bioorthogonal labelling strategies that can serve 
this purpose is the reaction between a tetrazine and a strained alkene. In this type 
of reaction an electron-deficient diene, a tetrazine, is reacted with a strained 
alkene such as norbornene. This reaction does not interfere with thiol groups and 
has evolved in both selectivity and fast kinetics. Moreover, the tetrazine reaction 
has been well exploited and optimised for several in situ and in vivo applications.2, 
3  
In chapter 4 an in-depth analysis of gold and fluorescence labelling for EM-
imaging is presented. Upon comparison of both labelling strategies it is shown 
that, if epitopes of interest are found in various structures within the same 
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specimen, there exist inherent discrepancies between the fluorescence signals 
and the distribution of gold particles. However, since gold labelling has great 
advantages regarding its punctate readout, it is desirable to look into alternative 
methods that can reach the punctuality benefits of the gold particles. One of 
these alternative strategies; the implementation of super-resolution imaging in a 
CLEM imaging sequence4, has been demonstrated in chapter 6, where it is shown 
that stochastic optical reconstruction microscopy (STORM) imaging can be 
succesfully perfomed on ultrathin cryosections without affecting EM-detectable 
cellular ultrastructures. In addition to this STORM-CLEM strategy, labels capable 
of polymerising DAB could also serve as a suitable alternative for gold particle 
labelling. Recently Ngo et al. have reported the use of a DAB polymerisation 
strategy for the EM detection of bioorthogonally-labelled biomolecules.5, 6 Ngo et 
al. labelled bioorthogonal groups with fluorophores capable of photoconverting 
triplet oxygen to singlet oxygen. These singlet-oxygen species can precipitate DAB 
which results in the formation of insoluble DAB precipitates within four 
nanometers of the original fluorophore. Due to the close proximity at which DAB 
precipitation occurs, biomolecules -tagged with bioorthogonal functionality- are 
labelled with high resolution, making this strategy a suitable alternative to gold 
labelling (Figure 1).6 However, since Ngo et al. use resin polymerisation for their 
study, this strategy is not compatible with on-section CLEM, precluding any type 
of additional on-section (immuno)-labelling and the ability to retrieve the exact 
same region of interest with both fluorescent and EM detection.  
Figure 1: Detection of bioorthogonal groups in resin embedded EM samples: A) First, a 
bioorthogonal uridine analogue is metabolicially incorporated in nascent DNA. This handle was 
modified at the end of the experiment with dibromofluorescein, which can efficiently convert triplet 
oxygen into singlet oxygen. This singlet oxygen can then convert a 3,3′-diaminbenzidine (DAB) 
substrate into an insoluble polymer with high affinity for osmium. This osmium is electron dense and 




In chapter 5 the CLEM detection of bioorthogonal labels described in chapter 3, 
is applied to the imaging of bacterial degradation in the phagolysosomal system of 
phagocytic cells. The in situ study of bacteria in the phagocytic pathway is very 
difficult, as genetic modification is complicated for certain pathogens and -if  
successful- only allows tracking of pathogen phagocytosis until the point where 
the genetically-introduced reporter proteins are degraded by the proteolysis that 
is the hallmark of normal phagosomal maturation. In chapter 5 it is shown that 
detection of bioorthogonal groups by CLEM allows one to obtain high resolution 
information on the subcellular location of the degrading bacteria, even after the 
signal of the genetically encoded protein reporters has gone.  
In chapter 6 the CLEM strategy reported in chapter 5 is applied to the imaging of 
bioorthogonally-labelled Salmonella Typhimurium upon implementation of 
STORM super-resolution imaging. This strategy has great potential to elucidate 
the temporal and spatial injection of Salmonella virulence factors and their 
interactions with host cells organelles. To further characterise the effects of single 
virulence factors on host-organelle organisation and morphology it is desirable to 
additionally apply this strategy on host cells infected with Salmonella mutant 
strains, such as Δssej and ΔsopB that are known for their attenuated virulence.7, 8 
Of additional importance would be to unravel how Salmonella affects the 
architecture of host-cell organelles. Although the in chapter 6 reported CLEM 
strategy can provide valuable information on the ultrastructural 2D architecture 
of the host-cell organelles, it does not provide comprehensive information on 
relative organelle organisation and their alterations upon Salmonella infection. 
This information can only be obtained upon reconstructing a volumetric 3D image 
of the obtained cellular ultrastructures. The classic approach for doing this, is by 
the reassembly and 3D reconstruction of TEM images from sequential sections.9 
This classic 3D reconstruction strategy is compatible with the here presented 
CLEM imaging of bioorthogonal labels; however, with this method only a limited 
number of sections can be reconstructed into a 3D volume. Other approaches, 
such as serial block-face (SBF) and focused-ion beam (FIB) milling and scanning 
electron microscopy (SEM) might therefore serve as good alternatives. With these 
approaches faster reconstruction can be performed of large volumes with a 
resolution that is close to that obtained with TEM.9 However, the main 
disadvantage of these approaches is that they are poorly compatible with 
fluorescence labelling and imaging due to chemical fixation, resin embedding and 
block staining.9 In case fluorescence imaging is desirable, it must therefore be 
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performed prior to SBF- and FIB-SEM imaging.10  Staining upon DAB precipitation, 
as presented by Ngo et al., therefore serves as a good staining alternative for SBF- 
and FIB-SEM imaging, albeit that with this type of labelling only one single 
biomolecule (class) of interest can be labelled per specimen.5, 6  
In chapter 7, CLEM imaging of active enzyme populations is explored. CLEM 
imaging of active cysteine protease populations are demonstrated using both 
two-step and direct activity based probe (ABP)-labelling approaches. It is shown 
that with both strategies active populations of cysteine proteases can be labelled 
in a similar fashion with high selectivity and efficiency. In addition it is shown that 
with direct ABPs multiple enzyme populations can be simultaneously CLEM 
imaged. Further improvement of the ultrastructural detection of active enzyme 
populations could be achieved upon use of ABPs that become fluorescent upon 
binding of the enzymatic product. These quenched ABPs (qABPs) are intrinsically 
quenched, but fluorescently label the target enzyme upon binding by a 
mechanism-based nucleophilic displacement of the quencher group. In this 
manner background levels of unbound ABP are lowered, resulting in an improved 
signal to noise ration. The development of such probes has been initially 
described by Blum et al., who developed qABPs to dynamically image cysteine 
protease activity in real time with decreased background levels.11, 12 Since the 
development of these probes a variety of qABPs have been generated, including 
2,3,5,6-tetrafluoro phenoxymethyl ketone (PMK)-modified probes, with greatly 
improved in vivo stability. An example of such a PMK probe is the fluorescently 
quenched pan-cathepsin probe BMV109, reported by Verdoes et al.13 Verdoes and 
co-workers additionally showed that upon modification of the peptide scaffold of 
BMV109, non-peptidic analogs could be developed with a high selectivity for 










1. L. I. Willems, N. Li, B. I. Florea, M. Ruben, G. A. van der Marel and H. S. 
Overkleeft, Angew Chem Int Ed Engl, 2012, 51, 4431-4434. 
2. N. K. Devaraj, R. Weissleder and S. A. Hilderbrand, Bioconjug Chem, 2008, 
19, 2297-2299. 
3. D. M. Patterson, L. A. Nazarova, B. Xie, D. N. Kamber and J. A. Prescher, J 
Am Chem Soc, 2012, 134, 18638-18643. 
4. B. G. Kopek, M. G. Paez-Segala, G. Shtengel, K. A. Sochacki, M. G. Sun, Y. 
Wang, C. S. Xu, S. B. van Engelenburg, J. W. Taraska, L. L. Looger and H. F. 
Hess, Nat Protoc, 2017, 12, 916-946. 
5. J. T. Ngo, S. R. Adams, T. J. Deerinck, D. Boassa, F. Rodriguez-Rivera, S. F. 
Palida, C. R. Bertozzi, M. H. Ellisman and R. Y. Tsien, Nat Chem Biol, 2016, 
12, 459-465. 
6. D. M. van Elsland and S. I. van Kasteren, Angew Chem Int Ed, 2016, 55, 
9472-9473. 
7. M. B. Ohlson, K. Fluhr, C. L. Birmingham, J. H. Brumell and S. I. Miller, 
Infect Immun, 2005, 73, 6249-6259. 
8. H. Ruan, Z. Zhang, L. Tian, S. Wang, S. Hu and J. J. Qiao, Biochem Biophys 
Res Commun, 2016, 478, 618-623. 
9. K. Miranda, W. Girard-Dias, M. Attias, W. de Souza and I. Ramos, Mol 
Reprod Dev, 2015, 82, 530-547. 
10. N. Jimenez, E. G. Van Donselaar, D. A. De Winter, K. Vocking, A. J. Verkleij 
and J. A. Post, J  microsc, 2010, 237, 208-220. 
11. G. Blum, S. R. Mullins, K. Keren, M. Fonovic, C. Jedeszko, M. J. Rice, B. F. 
Sloane and M. Bogyo, Nat Chem Biol, 2005, 1, 203-209. 
12. L. E. Edgington, M. Verdoes and M. Bogyo, Curr Opin Chem Biol, 2011, 15, 
798-805. 
13. M. Verdoes, K. Oresic Bender, E. Segal, W. A. van der Linden, S. Syed, N. P. 
Withana, L. E. Sanman and M. Bogyo, J Am Chem Soc, 2013, 135, 14726-
14730. 
14. K. Oresic Bender, L. Ofori, W. A. van der Linden, E. D. Mock, G. K. Datta, S. 
Chowdhury, H. Li, E. Segal, M. Sanchez Lopez, J. A. Ellman, C. G. Figdor, M. 
Bogyo and M. Verdoes, J Am Chem Soc, 2015, 137, 4771-4777. 
15. M. Verdoes, L. E. Edgington, F. A. Scheeren, M. Leyva, G. Blum, K. 





Om inzicht te krijgen in hoe biomoleculen cellulaire processen coördineren zijn er 
verschillende methoden ontwikkeld die het mogelijk maken om biomoleculen te 
bestuderen. Eén van deze strategieën is bioorthogonale chemie, een chemische 
markeringstechniek waarbij met behulp van een kleine chemische aanpassing 
biomoleculen ontvankelijk gemaakt voor detecteerbare labels. Bioorthogonale 
chemie kan worden toegepast bij onderzoek naar een veelvoud aan biomoleculen 
waaronder DNA, RNA, eiwitten, lipiden en suikers en heeft veel informatie 
opgeleverd over de  eigenschappen en interacties van deze biomoleculen. Echter 
is het tot dus ver niet mogelijk geweest om bioorthogonaal gelabelde 
biomoleculen te bestuderen in de context van de complete cellulaire omgeving. In 
dit proefschrift wordt de ontwikkeling en de toepassing van een methode 
beschreven waarbij, door het combineren van bioorthogonale chemie en 
elektronen microscopie, biomoleculen bestudeerd kunnen worden in de 
ultrastructurele context van hun cellulaire omgeving.  
In hoofdstuk 1 worden de algemene principes beschreven van electronen 
microscopie voor biochemisch onderzoek.  Allereerst worden twee verschillende 
elektronen microscopen beschreven; de ‘Scanning Electron Microscope’ (SEM) en 
de ‘Transmission Electron Microscope’ (TEM). Vervolgens worden verschillende 
preparatie technieken besproken die nodig zijn om biologische  monsters te 
bekijken met de TEM. Tot slot wordt er beschreven met welke reeds ontwikkelde  
strategieën biomoleculen gelokaliseerd kunnen worden in deze biologische TEM-
monsters. Eén van deze strategieën correlatieve licht en elektronen microscopie 
(CLEM) wordt verder uitgelegd aan de hand van twee strategieën; CLEM op 
levende cellen en CLEM op dunne coupes van cellen.  
In hoofdstuk 2 wordt het belang en de potentie benadrukt van bioorthogonale 
labellingsstrategiën voor CLEM. In dit review wordt een overzicht gegeven van 
veel gebruikte bioorthogonale labellingsstrategiën, onder andere; de koper 
gekatalyseerde Huisgen cycloadditie reactie, de ‘strain-promoted’ cycloadditie, de 
‘inverse electron-demand’ Diels-Alder cycloadditie en de ‘photoclick’ reactie. 
Hoofdstuk 2 bediscussieerd tevens welk onderzoek reeds is uitgevoerd op het 
gebied van bioorthogonale labellingsstrategieën en CLEM. Hieronder vallen onder 
andere strategieën zoals azide-gemodificeerde goud partikels, bioorthogonaal 
gefunctionalizeerde seleen/zink sulphine ‘core-shell quantum dots’ en 
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bioorthogonaal gefunctionalizeerde fluorophoren die in staat zijn om 
diaminobenzidine te foto oxideren.   
In hoofdstuk 3 worden twee methoden beschreven die zijn ontwikkeld om 
bioorthogonaal gelabelde biomoleculen te detecteren met de elektronen 
microscoop. In de eerste methode worden bioorthogonaal gelabelde 
biomoleculen direct in de elektronen microscoop gedetecteerd met behulp van 
colloïdale goud partikels. In het geval van de tweede strategie wordt er gebruik 
gemaakt van een CLEM methode waarbij allereerst bioorthogonale groepen 
fluorescent gelabeld worden en geïdentificeerd worden met een lichtmicroscoop. 
Vervolgens wordt er elektronen microscopie toegepast op dezelfde locaties 
waarna de informatie uit beiden microscopie strategieën aan elkaar wordt 
gekoppeld. Beide strategieën zijn toegepast om bioorthogonaal gelabelde 
bacteriën te identificeren in een mengsel van ongelabelde bacteriën.  
In hoofdstuk 4 wordt een grondige analyse beschreven van goud en fluorescentie 
labelling voor EM. Door het vergelijken van beide strategieën wordt aangetoond 
dat -indien epitopen aanwezig zijn in verschillende cellulaire structuren- er 
verschillen bestaan tussen de fluorescentiesignalen en de verdeling van goud 
partikels. Dit is aangetoond en gekarakteriseerd met behulp van de technieken 
die zijn beschreven in hoofdstuk 3; de labelling van bioorthogonale groepen met 
zowel goud als fluorescentie. 
In hoofdstuk 5 wordt de CLEM detectie van bioorthogonale labels toegepast om 
bacteriële afbraak in het fagolysosomale stelsel van fagocytische cellen te 
bestuderen. Onderzoek naar de afbraak van bacteriën in fagocytische cellen is 
problematisch aangezien de genetische modificatie van pathogenen 
gecompliceerd is en –indien succesvol- alleen gebruikt kan worden tot het punt 
waarop de genetisch geïntroduceerde markerings-eiwitten worden afgebroken. In 
hoofdstuk 5 wordt aangetoond dat de CLEM-detectie van bioorthogonale 
groepen het mogelijk maakt om met zeer hoge resolutie de sub-cellulaire locatie 
van gedegradeerde bacteriën te bestuderen, zelfs nadat het signaal van de 
genetische reporter constructen verloren zijn gegaan. 
In hoofdstuk 6 wordt geïllustreerd hoe implementatie van ‘stochastic optical 
reconstruction microscopy’ microscopie -in de gerapporteerde strategie van de 
hoofdstuk 5- kan worden toegepast om de sub-cellulaire locatie van Salmonella-
virulentiefactoren te bekijken. Deze strategie biedt de mogelijkheid om 
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virulentiefactoren die afkomstig zijn van pathogenen te bestuderen in de context 
van de gastheercel. Met behulp van deze strategie is het mogelijk om te 
bestuderen op welke manier de injectie van virulentiefactoren gastheercellen 
beïnvloed en hoe deze interacties veranderingen veroorzaken in de gastheercel. 
In hoofdstuk 7 word beschreven hoe actieve enzym populaties kunnen worden 
bestudeerd met behulp van ‘activity based probes’ (ABPs) en CLEM. In dit 
hoofdstuk wordt beschreven dat zowel met twee-staps als directe ABPs actieve 
cysteïneproteasen populaties kunnen worden bestudeerd in de context van 
cellulaire ultrastructuren. Bij het gebruik van zowel twee-staps als directe ABPs 
kunnen actieve populaties van cysteïneproteasen gedetecteerd worden met hoge 
selectiviteit en efficiëntie. Bovendien laat hoofdstuk 7 zien dat met behulp van 
directe ABP labelling meerdere enzym populaties kunnen worden bestudeerd met 
CLEM.  
In het concluderende hoofdstuk 8 worden alle bevindingen samengevat en 
worden er suggesties gegeven voor alternatieve technieken en toekomstige 
toepassingen, onder andere; labelling met behulp van diaminobenzidine 
precipitatie; het inbouwen van bioorthogonale aminozuren in Salmonella 
mutanten; 3D-CLEM van bioorthogonaal gelabelde bacteriën in fagocytische 
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